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ABSTRACT
The 85 kDa cytosolic phospholipase A2 (cPLA2) is an agonist-responsive 
effector for intracellular signal transduction through the arachidonate cascade. In vitro 
studies have demonstrated that this enzyme is regulated by sub-micromolar calcium and 
is specific for arachidonate as the sn-2 fatty acyl group of phospholipid substrates. 
However, very little data is available regarding in situ mechanisms which govern the 
activity of cPLA2. The primarily objective of these studies was to develop an in situ 
system for the study of cPLA2, and investigate mobilization of arachidonate during 
signal transduction events.
Dimethylsulfoxide differentiation of the human lymphoma cell line, U937, 
induced an enhanced capacity to mobilize arachidonate in response to the calcium 
ionophore A23187. The arachidonate mobilizing activity in differentiated cells was 
consistent with characteristics reported for cPLA2 in vitro. Although undifferentiated 
U937 cells have exceptionally high quantities of cPLA2, A23187-stimulated 
arachidonate mobilization was low, and not specific for arachidonate. Thus, 
differentiation of U937 induced cPLA2 regulatory elements that mediate arachidonate 
mobilization.
Differentiation induced significant changes in the capacitative pathway of 
intracellular calcium elevation. Both the size of intracellular calcium stores, as well as 
the characteristics of calcium influx channels were altered with differentiation. Agonist-
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stimulated arachidonate mobilization was coupled to these differentiation-induced 
alterations. cPLA2 activity was initiated upon agonist-stimulated depletion of 
intracellular calcium stores, and continued until maximum elevations of intracellular free 
calcium were attained. The data suggest that cPLA2 may be coupled to the generation 
of a calcium influx factor, which serves as a communication link between intracellular 
calcium stores and store-operated calcium influx channels. Consistent with this 
hypothesis, exogenous free arachidonate activated calcium influx in differentiated U937, 
consistent with activation of store-operated capacitative calcium influx channels.
Based on the data obtained in this study, a model for agonist-stimulated cPLA2 
activity is presented. This model suggests a novel role for cPLA^ Apart from the well 
known role in initiation of the arachidonate cascade, cPLA2 may be part of an 
intracellular effector system which regulates agonist-stimulated influx of extracellular 
calcium during activation of the capacitative pathway.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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CHAPTER ONE
INTRODUCTION
Arachidonic acid is a 20 carbon fatty acid, containing 4 double bonds. In 
resting mammalian cells, arachidonate is primarily found in its storage form, esterified 
to the sn-2 position of membrane phospholipids (1). Agonist stimulation by a diversity 
of compounds including thrombin (2, 3), bradykinin (4), cytokines (5), growth factors 
(6), vasopressin (7), platelet activating factor (8), and the non-hormonal calcium 
ionophore A23187 (1,4) result in liberation of free arachidonic acid. Arachidonate is 
mobilized from phospholipid stores by either direct or indirect pathways (Figure 1A). 
The indirect pathways involve phospholipid hydrolysis by phospholipases C (PLC) and 
D (PLD). Hydrolysis by PLD results in the formation of phosphatidic acid, which can 
be further hydrolyzed by the combined actions of phosphatidate phosphohydrolase and 
diglyceride lipase, yielding free arachidonic acid. Additionally, the combined actions 
PLC and diglyceride lipase can also yield free arachidonate. However, these two 
pathways are considered to provide only a minor contribution to the total agonist- 
stimulated arachidonate release (9). The primary mechanism for generation of free 
arachidonate is via the action of phospholipase A2 (PLA2), which hydrolyzes the ester
l
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FIGURE 1
A. PHOSPHOLEPASES INVOLVED IN RELEASE OF FREE 
ARACHIDONATE 
B. THE ARACHIDONATE CASCADE
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linkage of the fatty acid at the C2 position of a phospholipid molecule.
Once released, arachidonic acid is a key intermediate in a diversity of signal 
transduction pathways. Free arachidonate can be metabolized via three basic 
oxygenation pathways which comprise what is known as the arachidonate cascade 
(Figure IB). Metabolism by the cyclooxygenase pathway results in the formation of 
prostaglandins, thromboxanes, and prostacyclin. The lipoxygenase pathway catalyzes 
the formation of leukotrienes, and hydroperoxy- and hydroxy-eicosatetraenoic acids 
(HPETES & HETES). Finally, cytochrome P450 epoxygenases catalyze the NADPH- 
dependent formation of epoxyeicosatrienoic acids (EETS). Taken together, these 20- 
carbon oxygenated metabolites of arachidonate are collectively known as 
“eicosanoids”. Eicosanoids are potent lipid mediators, which differentially regulate a 
wide range of responses including cell growth, vascular and bronchial smooth muscle 
tone, platelet aggregation, tissue injury, allergy, and the inflammatory response (8, 10, 
11). It has also been suggested that arachidonate itself may be directly involved in 
signal transduction via the regulation of intracellular free calcium ([Ca2+]i) levels (12- 
14), mediation of growth and differentiation (15, 16), and regulation of low molecular 
weight GTPase activating proteins (17-19).
Regardless of the particular metabolic pathway taken by released arachidonate, 
the first and rate limiting step in the synthesis of these lipid mediators is the release of 
free arachidonate from membrane phospholipids, primarily by the action of PLA2 . As 
a first committed step to a biochemical pathway, it is expected that the action of PLA2  
is under stringent regulatory control. A comprehensive knowledge of these controlling 
elements will provide more effective treatment for pathological conditions related to
3
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activation of the arachidonate cascade.
Two forms of PLA2 have been implicated in the inflammatory response in 
mammalian tissues, each with distinctly different characteristics. A 14 kDa secretory 
PLA2 (sPLA2) has been isolated from extracellular fluids at inflammatory sites (20,21) 
and has been associated with extracellular propagation of the inflammatory response 
(22, 23). sPLA2 appears to contain a signal sequence, homologous to those of other 
secretory proteins, which directs secretion to the extracellular matrix in response to 
inflammatory stimuli (20, 25). Distinguishing properties of this enzyme include a lack 
of preference for sn-2 fatty acyl group and a millimolar calcium requirement (22). 
Although sPLA2 has long been considered the agonist responsive phospholipase 
involved in regulation of intracellular signal transduction through the arachidonate 
cascade, the characteristics of this enzyme suggest that this may not be so. 
Physiological intracellular calcium transients are in the sub-micro to micromolar range 
(6). The millimolar calcium requirement of sPLA2 implies that this enzyme may not 
function as an intracellular effector system for receptor mediated events. The lack of 
preference for fatty acyl substrate lends further support to this hypothesis.
An 85 kDa cytosolic PLA2 (cPLA2), has recently been identified in many cell 
types, including platelets (24), mast cells (5), pulmonary endothelium (25), adrenal 
chromaffin cells (26), U937 monocytic leukemia cells (27-29), and macrophages (30, 
31). This enzyme has no sequence homology with the 14 kDa sPLA2 (32). Unlike 
sPLA2, cPLA2 requires sub-micro to micromolar calcium for activation; which is 
within the range of [Ca2+]i concentrations. In further contrast to sPLA2, cPLA2 
exhibits a preference for sn-2 arachidonyl-containing phospholipid substrates (22, 31).
4
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A direct coupling between CPLA2 mediated arachidonate release and hormonal 
stimulation has been demonstrated in Chinese hamster ovary cells overexpressing 
transfected U937 cPLA2, but not in those overexpressing transfected sPLA2 (33). 
Furthermore, platelets that were depleted of sPLA2 by stimulation with platelet 
activating factor, were still capable of releasing thromboxane in response to a thrombin 
stimulus (34). This suggests that release of precursor arachidonate may not be 
mediated by sPLA2. These observations support the hypothesis that cPLA2 is an 
agonist responsive effector for signal transduction via the arachidonate cascade.
Current knowledge of cPLA2 suggests that it is regulated by two primary 
mechanisms: phosphorylation and calcium. The calcium requirements of cPLA2 have 
been determined in vitro using the purified U937 cell enzyme (28, 29,35), as well as in 
subcellular fractionation studies (28, 36). cPLA2 was found to translocate to 
membrane vesicle substrates in vitro at calcium concentrations above 150-300 nM. In 
fractionation studies, cPLA2 was found in the cytosolic fraction of cells which were 
disrupted in calcium-free medium. However if cells were disrupted in medium with a 
calcium concentration above 250-300 nM, the enzyme was found in the membrane 
fraction (28, 36). Although cPLA2 does not require calcium for catalysis (37, 38), 
calcium is required for association of the enzyme with membrane substrates (39). 
Sequence analysis of cPLA2 has identified an amino acid domain homologous to the 
calcium dependent lipid binding domain of protein kinase C (PKC), GTPase activating 
protein (GAP), and PLC, which is believed to participate in the calcium dependent 
translocation process (32).
Presumably, activation of cPLA2 requires translocation of the enzyme to
5
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membrane substrates in response to an increase in [Ca2+]i. However, much of the data 
on calcium dependent activation of CPLA2 has been obtained from in vitro experiments 
with purified enzyme. Direct correlations between physiological intracellular free 
calcium levels and in situ mobilization of arachidonate remain unclear. Although 
release of arachidonate has been observed following receptor mediated activation of 
various G  protein signal transduction pathways which elevate [Ca2+]i (13, 33, 40-43), 
we know very little about the effector mechanisms which couple receptor mediated 
events to translocation and activation of CPLA2 .
In addition to regulation by calcium, the activity of CPLA2 is further enhanced 
by serine\threonine phosphorylation in response to phorbol 12-myristate 13- acetate 
(PMA), thrombin, and ATP (33), as well as other agonists (30, 44). In vitro, 
phosphorylation results in increased release of arachidonate primarily due to an 
increase in the Vnux of the enzyme, while substrate affinity and calcium requirements 
remain unaltered (45). cPLA2 has been reported to contain multiple phosphorylation 
sites, and the extent of phosphorylation may vary with the type of stimulus (33, 46, 
47). Additionally, CPLA2 contains potential recognition sites for protein kinase C 
(PKC), protein kinase A (PKA), casein kinase II, and mitogen activated protein kinase 
(MAP kinase) (48). Various effector proteins have been identified in vitro as potential 
catalysts for phosphorylation of CPLA2 . PMA has been shown to potentiate 
arachidonate release in U937 and other cells (28, 33, 36, 49). Since PMA activates 
PKC (50, 51), and PKC is capable of phosphorylating CPLA2 in vitro (33, 47), it is 
possible that PKC may regulate in situ phosphorylation of CPLA2 . However treatment 
of cells with the PKC inhibitors staurosporine and sphingosine increased arachidonate
6
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mobilization in some cell lines (52, 53), while effects were inhibitory in others (33, 54). 
These results suggest potential involvement of PKC isoforms, which may be 
differentially inhibited (50).
Alternatively, other lines of evidence suggest regulation of effector proteins for 
cPLA2 phosphorylation via a kinase cascade, involving both PKC and non-PKC 
mediated events. In murine macrophages, zymosan-stimulated eicosanoid formation 
was inhibited by the tyrosine kinase inhibitors genistein and tyrphostin (55). This 
suggests that inhibition of tyrosine phosphoiylation may inhibit agonist-stimulated 
arachidonate release in some cells. Furthermore, treatment of macrophages and 
monocytes with the tyrosine phosphatase inhibitors orthovanadate (56) and okadaic 
acid (30) increased agonist stimulated arachidonate release. Although cPLA2 is not 
phosphorylated on tyrosine directly, it can be phosphorylated in vitro by MAP kinase 
(46, 57) which is in turn activated by both tyrosine and threonine phosphorylation (58, 
59). In U937 cells, PMA treatment resulted in activation of both MAP kinase and a 
MAP kinase activator (58). Thus PMA may potentiate arachidonate mobilization by 
activation of a tyrosine kinase upstream of effector proteins which phosphoiylate 
cPLA2 directly, such as MAP kinase. Furthermore, the calcium ionophore A23187, 
which stimulates arachidonate release in many cells (60) also increases tyrosine 
phosphorylation. Thus, in addition to the direct effects of calcium on the translocation 
of cPLA2, calcium may also affect upstream tyrosine kinases in a phosphorylation 
cascade which ultimately ends in phosphorylation of cPLA2.
Although phosphorylaton may increase the specific activity of cPLA2, an 
elevation in [Ca2+]; appears to be essential for initiation of hydrolysis. In the neutrophil
7
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(49), macrophage (30), and other cells (26), it has been reported that PMA alone is 
capable of activating arachidonate release, suggesting a role for phosphorylation alone 
in activation of cPLA* However it is unclear whether a calcium transient was also 
generated under the conditions used in these experiments, as neutrophils and 
macrophages are often activated during experimental manipulation (47, 61). In 
vasopressin-stimulated platelets (62), chemokine-stimulated monocytes (63), LPS- 
primed neutophils (64), and interleulkin-l-stimulated rat mesangial cells (35), 
phosphorylation of CPLA2 was an ineffective stimulus for arachidonate release, unless 
combined with a calcium signal. Thus, although phosphorylation further increases the 
in vitro activity of CPLA2, the actual intracellular effects of phosphorylation remain to 
be elucidated.
It has been suggested that a basal level of phosphorylated enzyme may exist in 
various cells, the activity of which is initiated by a calcium signal (47, 65). Additional 
phosphorylation might further increase enzymatic activity. However, in vitro 
experiments have demonstrated that the unphosphorylated enzyme is both active and 
responsive to calcium (33, 22). Alternatively, dual regulation of CPLA2 by both 
calcium and phosphorylation may occur. Whereas calcium transients initiate catalysis 
by activation of cPLA2-substrate association, the phosphorylation state of the enzyme 
regulates Vm*. Thus a calcium transient may initiate translocation and activation of 
the CPLA2 enzyme, the activity of which is further enhanced by phosphorylation.
In summary, in vitro studies have shown that CPLA2 is regulated by both 
calcium, and phosphorylation. However, in situ regulation of arachidonate 
mobilization by CPLA2 remains unclear. Although many CPLA2 activating ligands have
8
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been identified, (9, 22, 33) we know very little about the effector mechanisms which 
transduce receptor mediated stimuli into activation of CPLA2 . This study is designed 
to elucidate in situ mechanisms by which CPLA2 is activated in U937 cells. The initial 
experiments presented in Chapter 3 were designed to identify a model cellular system 
for the study of CPLA2 . These experiments bypass receptor mediated stimulation, and 
focus on direct activation of CPLA2 in response to A23187-stimulated increases in 
intracellular free calcium. Arachidonate release in this system was characterized with 
respect to stimulation by both calcium and PMA. Results from these initial 
experiments provoked further investigation into intracellular calcium dynamics, and the 
coupling of these dynamics to CPLA2 activation, presented in Chapters 4 and 5. 
Chapter 6 examines intracellular calcium and CPLA2 activity during actual receptor 
mediated events. Finally, a model for CPLA2 regulation in response to agonist 
stimulation is presented in Chapter 7.
9




U937 histiocytic lymphoma cells (66) were obtained from the American Type 
Culture Collection (Rockville, MD). RPMI 1640 medium was purchased from Sigma 
(St. Louis, MO). Fetal calf serum was obtained from Hyclone (Logan, UT). 
Dulbecco's phosphate buffered saline (PBS), HEPES buffer, and glutamine, were 
purchased from GIBCO (Grand Island, NY). Fatty acid free bovine serum albumin 
was from ICN Immuno Biologicals (Lisle, EL). Calcium ionophore A23187, 
SKF96365, staurosporine, and thapsigargin were from Calbiochem (San Diego, Ca). 
Dimethylsulfoxide (DMSO), phorbol myristate acetate (PMA) and nordihydroguaretic 
acid (NDGA), were from Sigma (St. Louis, MO). Stock solutions of A23187, PMA, 
and thapsigargin were prepared in DMSO and stored at -20°C. For arachidonate 
release assays, working solutions were prepared daily in PBS/2.2 mM glucose 
containing 2.5 pM albumin. [3H]arachidonate (100 Ci/mmol) and [3H]oleate (10 
Ci/mmol) obtained from New England Nuclear (Boston, MA). Fura-2 AM was 
obtained from Molecular Probes (Eugene, OR). Thin layer chromatography plates 
were purchased from Supelco (Bellafonte, PA). Free fatty acids, phospholipids, and 
acylglycerol standards were from Sigma (St. Louis, MO) Prostaglandin B oligomer 
(PGBx) and HPLC standards were from Cayman Biochemical (Ann Arbor, MI). 
Econazole was obtained from R.W. Johnson Pharmaceutical Research Institute 
(Raritan, NJ). All other reagents were from Sigma (St. Louis, MO).
10
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2.2 Cell Culture
U937 cells were grown in suspension culture using RPMI medium 
supplemented with 2 mM glutamine, 10 mM HEPES, and 10% heat inactivated fetal 
calf serum. Cultures were maintained in a 37°C humidified incubator, with 5% C02.
Stock cultures were maintained at a cell density of less than 1 x 106 /ml. All
experiments utilized cells between generations 4 and 26 in our laboratory.
For differentiation of U937 cells, cultures were seeded at an initial density of 0.2 x
106/ml, and were differentiated in growth medium supplemented with 1.5% DMSO (v/v)
$
for 96 hours. Cell density was maintained at or below 0.8 x 10 cells/ml during the 
differentiation process by addition of fresh growth medium supplemented with 1.5% 
DMSO. Cell viability was monitored by trypan blue exclusion, and was greater than 99% 
during the differentiation time course.
Differentiation was monitored by growth cessation (as determined by cell count) 
and development of the capacity to reduce nitro-blue tetrazolium (NBT) (67). Reduction 
of NBT is characteristically used for assessment of the macrophage phenotype (68). 
Briefly, 2 x 106 cells were centrifuged and resuspended in 1.0 ml Dulbecco’s phosphate 
buffered saline (PBS). One ml of 0.2% NBT (w/v) solution and 0.16 jiM PMA were 
added, and the cells were incubated at 37°C for 30 minutes in a shaking water bath. After 
incubation, a smear of the cell suspension was prepared on a glass slide. Cells capable of 
reducing NBT contained purple-black formozan granules intracellularly. Results were 
tabulated by microscopic evaluation, as a percentage of cells reducing NBT. A minimum 
of 150 cells were counted. In undifferentiated U937 cell cultures 8-10% of the cells
11
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reduced NBT. After the 96 hour differentiation period, >90% of the cells reduced NBT.
2.3 Radiolabeling
Differentiated or undifferentiated cells were radiolabeled by addition of
3 6 3 6[ H]arachidonate (0.1 pCi/10 cells) or [ H]oleate (0.2 pCi/10 cells) to the growth 
medium 24 hours prior to assay. 82 -85 % of the radiolabel was incorporated 
intracellularly during this period. After the labeling period, cells were washed once with 
PBS supplemented with 2.2 mM glucose and 2.5 pM albumin.
To determine the amount of radioactivity incorporated into phospholipids, 
aliquots of labeled cells were extracted according to the method of Bligh & Dyer (69). 
Extracts were thin layer chromatographed in the solvent system petroleum ether/diethyl 
ether/glacial acetic acid (82:18:1). Phospholipids, mono-, di-, and triacylglycerols, and 
free fatty acids were identified by co-chromatography of authentic standards. 
Radioactivity in the various lipid classes was quantitated using a Bioscan (Washington, 
DC) radioactivity scanner. Results confirmed that 96-99% of the radiolabel was present 
in phospholipid. Thin layer chromatography using the solvent system 
chloroform/methanol/glacial acetic acid/water (50:30:8:3) confirmed that
3
[ H]arachidonate was similarly distributed within the phospholipid classes of 
differentiated and undifferentiated cells.
2.4 Stimulation of fatty acid mobilization
[3H]Arachidonate labeled U937 cells were resuspended in
12
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PBS/glucose/albumin (Section 2.3). Aliquots containing 1 x 106 cells, were pre­
incubated for 10 minutes at 37°C in 0.8 ml PBS/glucose/albumin with or without PMA 
(10 nM). Where indicated, soluble diglycerides, EGTA, or inhibitors (NDGA, PGBx, 
econazole, SKF96365, Ni2+) were added during this initial pre-incubation period. 
PBS/glucose/albumin containing A23187, thapsigargin, fatty acids, or receptor- 
mediated agonists were then added in a volume of 0.2 ml, and the cells were incubated 
for an additional time period (2-10  minutes as indicated in Figure legends). The final 
assay volume was 1.0 ml in all cases. Controls consisted of cells treated with PBS ± 
PMA (and/or inhibitors); but without further stimulation. Reactions were stopped by 
rapid centrifugation in a microfuge at 1600 x g for two minutes. Aliquots of the 
supernatants were removed and radioactivity was quantitated by liquid scintillation. 
Release of radiolabel was expressed as a percentage of the total incorporated cellular 
radioactivity.
Release of phospholipid into the medium can indicate ceil damage during the 
incubation period. To monitor this, incubation supernatants from selected experiments 
were extracted according to the method of Bligh & Dyer (69). Aliquots of the lipid 
extracts were chromatographed against authentic lipid standards in the solvent system 
petroleum ether/diethyl ether/glacial acetic acid (82:18:1). Results confirmed that the 
agonist-stimulated release of radiolabel was in the free fatty acid form (>95%).
Cell viability after the incubation period was monitored by tiypan blue 
exclusion. Cell viability was greater than 98% under all incubation conditions, except 
A23187 doses in excess of 5 pM. Long term survival rates were assessed by washing 
agonist treated cells twice in PBS/glucose/albumin, resuspending the cells in growth
13
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medium, and determining cell number and trypan blue viability 1 hour post treatment.
For experiments in which arachidonate release was measured in Ca2+ free 
medium, or in the presence of extracellular strontium, radiolabeled cells were washed 
twice in Ca2+ free PBS, and resuspended in the same. AH reagents used were also 
prepared in Ca2+ free PBS. Strontium or calcium (1.1 mM) was added just prior to the 
initial ten minute pre-incubation.
2.5 Time course of differentiation
For these experiments, cells were differentiated with 1.5% DMSO as described 
above. At 12 hour intervals, replicate flasks were assayed for agonist-stimulated
3
arachidonate mobilization. For all time points assayed, [ H]arachidonate was added to 
the culture medium 24 hours prior to assay, except for the 12 hour time point, which was 
radiolabeled 12 hours prior to agonist stimulation. The zero time point utilized 
radiolabeled cells at a density of 0 . 2  x 1 0 6/ml (initial differentiation density) that had not 
been treated with DMSO. Cell viability, growth, and NBT reduction were assessed at 
each time point.
2.6 Time course of A23187-stimulated arachidonate release
Cells were radiolabeled and stimulated as described above. Reactions were 
stopped by addition of methanol at various time intervals after thapsigargin, ATP, or 
fMLP stimulation. Controls consisted of radiolabeled cells incubated for similar time 
intervals, without agonist stimulation. After addition of methanol, phosphatidylcholine
14
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(10 jig in 2 jil) and cold arachidonate (5jig in 2 jil) were added as carrier to minimize loss 
of lipids during extraction. The combined cells and incubation medium were extracted, 
concentrated under nitrogen, and stored at -20°C. Extracts were chromatographed using 
the solvent system petroleum ether/diethyl ether/glacial acetic acid (82:18:1). 
Phospholipids; mono-, di-, and triacylglycerols, and free arachidonate, were identified by 
co-chromatography of authentic lipid standards. Results were quantitated using a 
Bioscan radioactivity scanner. No changes in radioactivity associated with mono or 
diglyceride fractions were observed during the time course of thapsigargin stimulation.
Comparison of arachidonate release measured using methanol to stop agonist- 
stimulated reactions, with those obtained by stopping the reaction with centrifugation, 
confirmed that both methods produced similar results for incubation times > two minutes. 
However, arachidonate release at earlier time points could not be accurately measured 
using the centrifugation method.
Released arachidonate can be re-incorporated into cellular triglycerides (9, 70) 
following agonist stimulation. Re-incorporation can therefore result in an 
underestimation of actual agonist-stimulated arachidonate release. Thus, re­
incorporation was measured by determining radiolabel present in the triglyceride fraction. 
Re-incorporation of arachidonate, as evidenced by increased radioactivity in the 
triacylglycerol fraction, was minimal (less than 1 .0 % of radiolabeled cellular lipids) from 
0  to 3 minutes post thapsigargin.
2.7 Analysis of P450 arachidonate metabolites: thin layer chromatography.
For analysis of cytochrome P450 arachidonate metabolites, 2 x 106 radiolabeled
15
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cells were pre-incubated for ten minutes at 37°C in 1.6 ml PBS/glucose/albumin, with or 
without PMA (10 nM). PBS/glucose/albumin containing 1 pM thapsigargin was then 
added in a volume of 0.4 ml. The final incubation volume was 2 . 0  ml. An increased cell 
number is utilized for these experiments to assure adequate detection of small amounts of 
arachidonate metabolites. Reactions were stopped by addition of methanol, and were 
extracted and concentrated under nitrogen as previously described. Extracts were thin 
layer chromatographed using the solvent system ethyl acetate/iso-octane/acetic 
acid/water (110:50:20:100) (71). The solvent system was prepared in a separatory 
funnel, mixed well, and allowed to stand until phases separated (approx. 5 minutes). The 
organic phase was used for thin layer chromatography. Prostaglandins, leukotrienes, free 
arachidonate, and P450 arachidonate metabolites were identified by co-chromatography 
of authentic lipid standards. Results were quantitated using a Bioscan radioactivity 
scanner. Further confirmation of the identity of arachidonate metabolites was obtained 
using indomethacin to inhibit the cyclooxygenase pathway as described in Section 5.2.3. 
Any metabolites formed that were not inhibited by indomethacin would be either 
cytochrome P450 or lipoxygenase metabolites.
2.8 Analysis of P450 arachidonate metabolites: HPLC
For HPLC analysis of agonist-stimulated arachidonate metabolites, radiolabeled 
cells were incubated in a final volume of 2.0 ml, (+ PMA, + indomethacin) as described in 
section 2.7. Reactions were stopped by rapid centrifugation. The resultant supernatants 
were removed and acidified to pH 4.0 with 20 pi 10% formic acid, and extracted twee 
with two volumes of ethyl acetate. Extracts were concentrated under nitrogen, and
16
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stored at -20°C. For HPLC, extracts were dried under nitrogen and resuspended in 0.5 
ml of methanol/water (70/30). Arachidonate metabolites were separated by HPLC 
(Beckman Instruments Inc., Fullerton, CA) on a reversed phase C-18 column (Beckman 
ODS, 4.6 mm x 250 mm) with a flow rate of 1 ml/minute. After a five minute elution of 
the column with methanol/water/phosphoric acid (550/450/2 pH 5.7) the methanol 
composition was increased from 55 to 100% over 35 minutes. Lipoxygenase metabolites 
were detected by in line UV absorption at 270 nm (235 nm for 5-HETE). For detection 
of prostaglandins, P450 arachidonate metabolites, lipoxygenase metabolites, and free 
arachidonate, column effluent fractions were collected at 1 minute intervals. 
Radioactivity in the fractions was determined by liquid scintillation. Radiolabeled 
arachidonate metabolites were identified by their reported retention times (72).
2.9 Intracellular Free Calcium
Differentiated or undifferentiated cells were centrifuged and resuspended in 
PBS/albumin/glucose at a density of 2 x 1 0 6 cells/ml. Cells were loaded with Fura- 
2/AM (5 pM) at 37°C for 1 hour. After loading, cells were then centrifuged to 
remove unincorporated Fura-2/AM, and resuspended in PBS/glucose/albumin with or 
without calcium as indicated. Aliquots of cell suspension (500 pi) were added to the 
spectrofluorometer cuvette, maintained at 37°C with stirring, and measurements were 
initiated. Cells were stimulated with DMSO solutions (2.5-5 pi) of A23187 or 
thapsigargin. Addition of this volume of DMSO to Fura-2 loaded cells did not affect 
[Ca2+]i. Although A23187 is reported to have intrinsic fluorescence, A23187 (< 2 
pM) did not contribute to background fluorescence under the conditions utilized in 
these experiments.
17
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[Ca2+]j was measured in a SPEX ARCM spectrofluorometer. The excitation 
wavelengths were 340 and 380 nm, and emission was measured at 510 nm. [Ca2+]i 
was calculated using the equation of Grynkiewicz (73):
[Ca ]i ~  K j x  (R - Rmin) x _Sg 
(Rmax _ R )  Sb2
Briefly, autofluorescence was determined using aliquots of unloaded cells, and was 
subtracted from all measurements. The Fura-2 signal was calibrated in loaded cells by 
addition of 0 .1 % (w/v) digitonin (to obtain the fluorescence with maximum calcium at 
340 and 380 nm;), followed by 10 mM EGTA (to obtain the fluorescence with 
minimum calcium at 340 and 380). R^* represents the ratio of Fura-2 fluorescence at 
340/380 nm in medium containing saturating concentrations of calcium (+ digitonin). 
Rmin represents the ratio of Fura-2 fluorescence at 340/380 nm in calcium free medium 
(+EGTA). Sf2 and Sb2 represent the fluorescence ratios of Fura-2 obtained at 380 nm 
in the absence and presence of saturating levels of calcium, respectively. For a given 
sample, computer driven measurements were made eveiy 0 . 1  second, and were 
averaged to obtain a data point at 1 second intervals. For each data point the 
fluorescence values obtained following excitation at 340 nm were divided by those 
obtained at 380 nm giving a corrected ratio (R). [Ca2+]i was then calculated by a 
computer program designed for the spectrofluorometer, using the equation given 
above. The K4  for the Fura-2/calcium complex was assumed to be 224 nM at 37°C. 
The final result was an experimental trace of [Ca2+],- versus time.
18
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For PMA pre-incubations, aliquots of Fura-2 loaded cells were incubated with 
10 nM PMA for 10 minutes at 37°C. Where indicated, EGTA (1 mM), NDGA (20-40 
pM), PGBx (10-50 pg/ml), econazole (2pM), and SKF96365 (1 pM) were added 2 
minutes prior to thapsigargin stimulation.
For experiments in which strontium was used as a surrogate for calcium, cells 
were loaded with Fura-2 as described above. After Fura-2 loading, cells were washed 
twice in calcium free PBS, and resuspended in the same. Si2* or Ca2+ (1 mM, 2.5 pi) 
were added to cells immediately prior to addition of thapsigargin. Intracellular Sr*+ 
was quantitated as described above, using a dissociation constant of 510 nM for the 
Fura-2/Sr2+ complex (74-76).
To examine the effects of free fatty acids (arachidonic, linoleic, oleic) on 
[Ca2+]i , cells were loaded as described above, washed, and resuspended in 
PBS/glucose with or without albumin as indicated in figures. Stock solutions of fatty 
acids were prepared in ethanol. Working dilutions of the free fatty acids were 
prepared daily in PBS by sonication of an aliquot of the concentrated stock. 
Concentrations of ethanol in experimental measurements did not exceed 0.1%.
To examine receptor-mediated events, ATP and the chemotactic peptide N- 
formyl-methionyl-L-leucyl-L-phenylalanine (fMLP), were added to 0.5 ml of cell 
suspension in the cuvette using a volume of 2.5 - 5.0 pi. [Ca2+]i was measured as 
described above.
2.10 Statistics
Data points, except where indicated in figure legends, represent the mean +
19
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
standard error of the mean (SE) for a minimum of 3 experiments performed in 
duplicate.
For most data points, the actual number of individual experiments averaged to obtain 
the mean exceeds 3, and this is indicated in figure legends. Statistical significance was 
determined by Student’s T test. A probability of 0.05 or less was considered 
significant.
20
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CHAPTER 3
EFFECTS OF DMSO-INDUCED DIFFERENTIATION ON ARACHIDONATE 
MOBILIZATION IN THE HUMAN HISTIOCYTIC LYMPHOMA CELL LINE 
U937: RESPONSIVENESS TO SUB-MICROMOLAR CALCIUM 
IONOPHORE A23187 AND PHORBOL ESTERS.
3.1 Background
Although cPLAj has been extensively characterized in vitro (22), very little data
is available regarding in situ regulation. Initial studies were designed to establish a 
model cellular system in which cPLA2  could be effectively studied. The human 
histiocytic lymphoma cell line U937, is a rich source for cPLA2 and has been a standard 
cell line for purification of the human enzyme (27-29, 77, 78). We therefore chose to 
investigate arachidonate release in U937 cells, as a potential model system for studying 
regulation of cPLAj.
U937 is a transformed cell line of the myeloid lineage, considered to represent a 
pre-macrophage. The development of U937 cells has been arrested late in hematopoetic 
development, after the commitment to neutrophil or macrophage has been made (6 6 ,
21
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6 8 ). Differentiation of U937 with DMSO and other agents induces morphological and 
functional maturation into a macrophage-like cell. Differentiated cells display growth 
inhibition, alterations in surface glycoproteins, reduction of NBT, development of the 
chemotactic response, and phagocytosis (6 8 ). However, reports indicate that the 
intrinsically high levels of cPLA^ in U937 increase only slightly with differentiation (32,
77-80).
In order to identify U937 as a model cellular system for in situ study of cPLA^
one must first demonstrate arachidonate mobilization in response to agonist stimulation. 
Secondly, arachidonate mobilization should be consistent with the characteristics 
reported for cPLA^ in vitro (responsiveness to low calcium and specificity for
arachidonate). The results presented in this Chapter represent experiments designed to 
define such a system in U937. These initial experiments utilized the calcium ionophore 
A23187 as an agonist for cPLAj activation. We reasoned that use of A23187 to
directly elevate [Ca2+]i, would activate cPLA^ independent of any complications related
to receptor-mediated events. Unexpectedly, our observations indicate that, although 
undifferentiated U937 cells contain considerable amounts of functional cPLA ,^
arachidonate release is only weakly stimulated by the calcium ionophore A23187. 
Dimethylsulfoxide (DMSO) differentiation of U937 dramatically enhances A23187 
stimulatable arachidonate mobilization. Furthermore, the characteristics of this response 
are consistent with those reported for cPLAj in vitro. Our observations suggest that
differentiation may induce cPLAj regulatory elements which are inactive in
undifferentiated cells.
22
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3.2 Results
3.2.1 EfTects of calcium ionophore A23187 on arachidonate release in 
differentiated and undifferentiated U937 cells.
Our initial investigations examined the calcium ionophore A23187-stimulated 
release of [3H]arachidonate from undifferentiated U937 cells. A23187 transports 
calcium across biological membranes, down its concentration gradient (81). Exposure 
to A23187 thereby results in an elevation of [Ca2+]j, independent of plasma membrane- 
receptor mediated events. Since cPLAj is activated by elevations in [Ca2+]i, we
reasoned that A23187 should activate arachidonate mobilization in undifferentiated 
U937. However, in contrast to the high levels of extractable enzyme in U937 cells, 
A23187 stimulatable arachidonate mobilization in undifferentiated cells was low and 
only weakly dose-dependent on A23187 (Figure 2). A23187 stimulated release of
incorporated [3H]arachidonate was only 1 - 2 % above basal (unstimulated) release of 
radiolabel at A23187 concentrations below 2.5 pM.
DMSO differentiation of U937 cells induced a dramatic alteration in A23187- 
stimulated arachidonate release (Figure 2). Differentiated cells exhibited a 2-4 fold 
increase in release of arachidonate in response to A23187 as compared to 
undifferentiated cells. Differentiated cells also exhibited an increased sensitivity to 
concentrations of A23187 in the sub-micromolar range. Furthermore, the dose- 
response curve for differentiated cells was biphasic, with an initial rapid increase over 
the A23187 concentration range 0.05-0.3 pM. This initial increase was followed by a
23
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FIGURE 2.
EFFECTS OF DMSO-INDUCED DIFFERENTIATION ON A23187-
STTMULATED [3 H]ARACHIDONATE RELEASE IN U937 CELLS.
U937 cells were cultured and differentiated with DMSO as described in Methods
3section 2.2. Cells were labeled with [ H]arachidonate during the last 24 hours as 
described in 2.3. Radiolabeled cells were washed and resuspended in 
PBS/glucose/albumin. Arachidonate release was stimulated with calcium ionophore 
A23187 as described in Methods section 2.4. Results represent mean ± SE of 5 
separate experiments performed in duplicate.
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plateau, during which arachidonate release remaned at the same level of activity (0.3- 
0.8 pM A23187). A second increase occurred over the concentration range 1.25 - 10
pM; during which release of [^HJarachidonate approached 15%.
Cell viability at all A23187 concentrations tested was greater than 99%, except 
at 10 pM. A 3-4 % initial loss of viability was observed at this A23187 dose. 
However, the 1 hour survival rate of cells exposed to 10 pM ionophore, washed, and 
returned to incubation medium was only 60-70%. Furthermore, considerable amounts 
of radiolabeled phospholipid were released during incubations with 5-10 pM A23187 
(30-40% of the released radioactivity was phospholipid at 10 pM A23187, data not 
shown). Thus, the response to A23187 concentrations of 5 pM and above are markedly 
different from that observed with A23187 concentrations less than 2.5 pM, where 
>95% of the released radioactivity was free arachidonate (data not shown). The 
increased release of phospholipid, combined with the decrease in viability observed, may 
indicate cytotoxic effects of A23187 at concentrations above 5 pM. Similar effects 
have been reported in other cell lines (82, 83). Subsequent experiments utilized 
ionophore concentrations of 2.5 pM or less.
3.2.2 Effects of PMA on A23187-stimulated arachidonate release
PMA has been shown to enhance agonist-stimulated arachidonate mobilization 
in several cell types (33, 47). This synergism may be due, in part, to PMA induced 
activation of protein kinase C (PKC). Activation of PKC results in phosphorylation of 
cPLAy thereby enhancing enzymatic activity (47, 53, 57). We therefore examined the 
effects of PMA on A23187-stimulated arachidonate mobilization in U937 cells.
25
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Differentiated and undifferentiated U937 cells were incubated with PMA 
concentrations ranging from 1 to 100 nM and for incubation times from 10 minutes to 3 
hours. No significant stimulation of arachidonate mobilization was observed in either 
differentiated or undifferentiated U937 cells exposed to PMA alone (results not shown). 
This suggests that activation of PKC without a subsequent calcium signal (such as that 
provided by A23187) is an insufficient stimulus for arachidonate mobilization in U937 
cells.
In undifferentiated cells, a ten minute pre-incubation with PMA (10 nM) 
followed by A23187 challenge had no significant effect on A23187-stimulated 
arachidonate mobilization (Figure 3). Pre-incubation with higher concentrations of 
PMA (25-100 nM) were without additional effects. However, in differentiated cells, the 
priming effect of PMA on A23187 stimulated arachidonate release was quite 
pronounced (Figure 4). The PMA + A23187 dose-response retained the biphasic 
characteristics observed with A23187 alone, and PMA pre-incubation further 
potentiated this response by 4 to 6  fold. The most dramatic increases in arachidonate 
mobilization were evident at sub-micromolar to micromolar concentrations of A23187 
(0.04 - 1.25 pM). For example, PMA + A23187 (0.04 pM) resulted in a 14 % release 
of incorporated label, while 0.04 pM A23187 alone resulted in only a 3% release. The 
inactive isomer of PMA, 4 a  phorbol myristate acetate, was without effect in either 
differentiated of undifferentiated cells (data not shown).
26
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FIGURE 3.
EFFECTS OF PMA ON A23187-STIMULATED [3 H]ARACHIDONATE 
MOBILIZATION IN UNDIFFERENTIATED U937 CELLS. 
Undifferentiated cells were cultured and radiolabeled as described in Methods (2.2-2.3). 
Radiolabeled cells were resuspended in PBS/glucose/albumin and pre-incubated with 10 
nM PMA for ten minutes prior to A23187 challenge, as described in section 2.4. 
Results represent mean ± SE of 3 separate experiments performed in duplicate.
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FIGURE 4.
EFFECTS OF PMA ON A23187-STIMULATED [3 H]ARACHIDONATE 
MOBILIZATION IN DIFFERENTIATED U937 CELLS. 
Differentiated cells were prepared and radiolabeled as described in Methods (2.2-2.3). 
Radiolabeled cells were resuspended in PBS/glucose/albumin and pre-incubated with 10 
nM PMA for ten minutes prior to A23187 challenge, as described in section 2.4. 
Results represent mean + SE of 5 separate experiments performed in duplicate.
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3.2.3 Specificity of fatty acid release
cPLAj purified from U937 as well as other cell types exhibits a specificity for
phospholipids containing arachidonate in the sn-2 position (22). It was therefore of 
interest to examine the specificity of A23187-stimulated arachidonate release in 
differentiated U937 cells. For these experiments, differentiated and undifferentiated
3 3
cells were radiolabeled with [ H]oleate or [ H]arachidonate for 24 hours. Cells were 
pre-incubated with PMA and subsequently challenged with increasing concentrations of 
A23187. In undifferentiated cells, basal (unstimulated) release of both oleate and 
arachidonate were low (3-4% of incorporated radiolabel, Figure 5). Pre-incubation of 
undifferentiated cells with PMA, followed by A23187 challenge, did not significantly 
increase A23187-stimulated release of either fatty acid (Figure 5). Thus, A23187- 
stimulated fatty acid release in undifferentiated cells was not specific for arachidonate.
In differentiated cells, basal (unstimulated) release of oleate was low (2-3%) and 
only slightly higher than that of arachidonate. Concentrations of A23187 up to 1.25 pM 
did not stimulate release of oleate above basal levels (Figure 6 ). Consistent with 
activation of cPLA2, the PMA + A23187 stimulated release of free fatty acids in 
differentiated U937 cells is specific for arachidonate.
3.2.4 Effects of PMA and soluble diglycerides on A23187-sfimulated 
arachidonate release
Diacylglycerols are physiological activators of PKC (50). In the neutrophil, 
soluble diacylglycerol analogs such as 1,2-dioctanoylglycerol (diC8 ) and
29
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FIGURE 5.
SPECIFICITY OF PMA + A23187 STIMULATED [3H]ARACHIDONATE 
RELEASE IN UNDIFFERENTIATED U937.
Cells were cultured and radiolabeled with either [3H]arachidonate or [3H]oleate as 
described in Methods (2.3). Labeled cells were resuspended in PBS/albumin/glucose 
and pre-incubated with 10 nM PMA for 10 minutes, followed by A23187 challenge 
(Methods 2.4). Results shown represent mean ± SE of 3 separate experiments 
performed in duplicate.
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FIGURE 6.
SPECIFICITY OF PMA + A23187 STIMULATED fH]ARACHIDONATE 
RELEASE IN DIFFERENTIATED U937.
3 3
Cells were differentiated and radiolabeled with either [ Hjarachidonate or [ H]oleate as 
described in Methods (2.3). Labeled cells were resuspended in PBS/albumin/glucose 
and pre-incubated with 10 nM PMA for 10 minutes, followed by A23187 challenge 
(Methods 2.4). Results shown represent mean ±  SE of 3 separate experiments 
performed in duplicate. Error bars are too small to print.
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oleoylacetylglycerol (OAG) are equipotent with PMA in enhancement of A23187- 
stimulated arachidonate release (49). Therefore, we investigated the effects of these 
soluble diglycerides on arachidonate mobilization in differentiated U937 cells. Unlike 
results observed in the neutrophil, micromolar concentrations of the soluble diglycerides 
produced only a minor (10-20%) increase in A23187 stimulated arachidonate release in 
differentiated U937 cells (Figure 7A). In contrast, PMA potentiation of A23187- 
stimulated arachidonate release was dose-dependent, and maximal effects were 
observed at a relatively low (10 nM) concentration (Figure 7B). Thus, neither soluble 
diglyceride was as effective as PMA in potentiation of A23187-stimulated arachidonate 
mobilization in differentiated U937. It is possible that U937 cells lack the PKC- 
independent pathway by which soluble diglycerides prime arachidonate release in the 
neutrophil (84). However, diacylglycerols can be hydrolyzed by various esterases to 
yield glycerol and free fatty acids (51). Differentiated U937 contains high levels of non­
specific esterases (6 8 ) which may decrease the efficacy of diacylglycerols in these cells.
3.2.5 A23187-stimulated arachidonate release during the time course of 
differentiation.
Our observations indicated that DMSO-differentiation resulted in a marked
3
enhancement in both A23187 and PMA+A23187-stimulated [ H]arachidonate 
mobilization. We therefore sought to examine A23187 stimulated arachidonate 
mobilization during the temporal development of monocytic differentiation.
The normal doubling time for U937 cells in our laboratory is approximately 24 
hours. As can be seen from Figure 8 A, DMSO treatment significantly decreased this
32
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FIGURE 7.
EFFECTS OF PMA AND SOLUBLE DIGLYCERIDES ON A23187
STIMULATED [3H]ARACHIDONATE RELEASE IN DIFFERENTIATED U937
CELLS.
In figure 7A, differentiated cells were pre-incubated for 10 minutes in 
PBS/albumin/glucose containing either OAG or diC8 , at various concentrations as 
indicated in the figure. A23187 (1.25pM) was then added and the cells were incubated 
an additional 10 minutes (Methods 2.4). Results represent mean ± SD of 3 separate 
experiments. In figure 7B, differentiated cells were pre-incubated with increasing 
concentration of PMA for 10 minutes, followed by A23187 (1.25 pM) challenge as 
described above.
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FIGURE 8.
TIME COURSE OF DMSO DIFFERENTIATION: CELL GROWTH AND NBT
REDUCTION.
Cells were differentiated at an initial density of 0 . 2  x 10fi cells/ml as described in 
Methods 2.5. At 12 hour intervals aliquots of the cultures were removed and cell 
density (Figure 8 A) and NBT reduction (Figure 8 B) were determined as described in 
Methods 2.2. Results shown are representative of 3 separate experiments.
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growth rate. However, complete growth inhibition did not occur until 72 hours post 
DMSO. Cell viability at all time points analyzed was greater than 99%.
The capacity to reduce and phagocytose NBT was used as a marker for 
monocytic differentiation of U937 cells (67, 6 8 ). During the first 48 hours of 
differentiation, the percentage of cells reducing NBT increased in a linear manner, with 
80% of the cells reducing NBT by this time (Figure 8 B). Maximum development of 
NBT reduction did not occur until 72 - 84 hours post DMSO, at which point 90% of 
the cells were positive for NBT reduction. Thus, the development of the capacity to 
reduce NBT correlates with the onset of growth inhibition in differentiating U937 cells.
During the course of DMSO-induced differentiation, development of the 
A23187 response occurred at two distinct phases (Figure 9). Enhanced arachidonate 
release in response to 1.25 pM A23187 challenge was observed within 12 hours of 
DMSO exposure. Arachidonate release increased linearly until 36 hours post DMSO, 
and remained at this elevated level through 84 hours post DMSO. Between 84 and 96 
hours post DMSO, a second sharp increase in A23187-stimulated arachidonate 
mobilization was observed. This enhanced level of responsiveness was maintained 
through 144 hours post DMSO (data not shown). Therefore, the onset of maximal 
arachidonate mobilization in response to A23187 challenge correlates with both onset of 
growth inhibition and development of the capacity to reduce NBT.
In contrast, the ability of PMA to potentiate the A23187 response developed 
early in the differentiation time course (Figure 9). Maximal PMA effects were attained 
by 36 hours after initial DMSO treatment. PMA primed the 1.25 joM A23187 
stimulated arachidonate release by 2-3 fold during this early phase, and maintained a
35
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FIGURE 9.
TIME COURSE OF DMSO DIFFERENTIATION OF U937 CELLS: 
ARACHIDONATE MOBILIZATION.
3U937 cells were differentiated and radiolabeled with [ KQarachidonate as described m 
Methods 2.5. At 12 hour intervals after addition of DMSO, cells were evaluated for 
A23187 (1.25 pM) or PMA + A23187-stimulatable arachidonate mobilization, as 
described in Methods 2.4. Results shown are representative of 3 separate experiments.
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steady 1.5-2 fold enhancement throughout the time course of differentiation. Therefore, 
the second phase of increased arachidonate release observed at 96 hours appears to be 
primarily due to increases in the A23187 response rather than an increase in PMA 
potentiation.
3.3 DISCUSSION
Quite unexpectedly, our results indicate that undifferentiated U937 cells are only 
weakly stimulated to release arachidonate in response to the calcium ionophore 
A23187. Furthermore, A23187-stimulated release of fatty acids in undifferentiated 
U937 cells is not specific for arachidonate (as compared to oleate). In contrast to our in 
situ observations, cPLAj activity in high speed supernatants from undifferentiated whole
cell homogenates is quite high (27, 28, 29). Recent reports indicate that only modest 
(less than 10-20%) increases in cPLAj protein are observed with DMSO differentiation 
(32, 77-80). Furthermore, purified enzyme from undifferentiated U937 cells as well as 
CPLA2 activity in U937 cell cytosol, are activated in vitro by physiological (150-600 
nM) calcium (29), indicating that the enzyme is indeed functional and responsive to 
calcium in undifferentiated cells.
In contrast, DMSO-dififerentiation of U937 cells results in significant 
enhancement of A23187 stimulatable arachidonate release. This implies that CPLA2  
regulatoiy elements may be lacking or non-functional in undifferentiated cells. The 
enhanced capacity to mobilize arachidonate observed in differentiated cells may be due 
to induction of these regulatory elements.
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The characteristics of the A23187 stimulatable mobilization of arachidonate in 
differentiated U937 cells are consistent with those observed for in vitro cPLAj (22); the
enzyme is activated by low levels of calcium and demonstrates a marked preference for 
arachidonate over oleate. In vitro activation of purified cPLA ,^ (29) and translocation of
the enzyme to membrane fractions of cell homogenates (27,28,44) is reported to occur 
at calcium concentrations in the micro to sub-micromolar range. Preliminary calcium 
measurements indicated that A23187 doses of 0.01-1 fiM do, indeed, correlate with 
intracellular free calcium concentrations within the sub-micro to micromolar range (data 
presented in Chapter 4). Our results indicate that arachidonate release observed at these 
low ionophore concentrations appears to be consistent with the physiological 
intracellular calcium elevations required for signal transduction and cPIA, activation. 
In fact, measurement of arachidonate release under conditions of sub-micromolar 
calcium may tend to rule out a major contribution to arachidonate release from sPIA, in
U937 cells.
In addition to regulation by calcium, the activity of cPIA^ is further enhanced by
serine/threonine phosphorylation in response to PMA, thrombin, ATP, and other 
agonists (31, 33, 42). Pre-incubation of differentiated U937 cells with PMA, followed 
by A23187 challenge, resulted in a synergistic potentiation of arachidonate mobilization. 
This "priming" effect of PMA on fatty acid mobilization exhibited a preference for 
arachidonate over oleate. The most dramatic PMA-induced effects (4-6 fold) were 
evident in differentiated cells stimulated with low doses of A23187. These observations 
suggest that PKC is involved in regulation of arachidonate mobilization in U937 cells.
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However the precise role of PKC is, at present, unclear. cPLAj is phosphoiylated and
activated by a MAP kinase in vitro (46, 57). In U937 cells, PMA activated both a MAP 
kinase and a MAP kinase activator (58). Thus, PMA may potentiate arachidonate 
mobilization in U937 cells by indirect activation of kinases which lie upstream of 
effector proteins such as MAP, which phosphorylate cPLA^ directly. However, as PMA
alone was without effect in either differentiated or undifferentiated cells, either mode 
(direct or indirect) of PMA-induced cPLAj phosphorylation may be insufficient to 
stimulate arachidonate mobilization in differentiated U937 cells unless combined with an 
elevation of [Ca2+]i, which brings cPLA^ in contact with its membrane substrate.
Since undifferentiated U937 cells contain substantial cPLAj activity, our results
suggest that the dramatic increases in arachidonate mobilization observed in 
differentiated cells may be due to induction of cPLAj regulatory elements. Two such
cPLAj regulatory elements are calcium, which regulates translocation; and
phosphorylation, which further enhances enzymatic activity. Although cPLAj does not
require calcium for catalysis (37, 38), it does require calcium for translocation to 
membrane phospholipid substrates. Thus, differentiation-induced changes in the 
capacity of intracellular calcium pools or extracellular calcium influx pathways could 
subsequently effect translocation of cPIAj and mobilization of arachidonate.
The present results suggest that differentiation may also induce changes in levels 
of PKC isoforms, or PKC substrates, which in turn regulate activity of cPLAj. PMA
pre-incubation does not enhance arachidonate release in undifferentiated cells, 
suggesting that the necessary phosphorylation mechanism may be lacking. The ability of
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PMA to potentiate A23187-stimulated arachidonate mobilization developed during the 
o
first 36 hours of differentiation, and remained at this level through 96 hours. In 
contrast, the dramatic increase in arachidonate release observed after 96 hours 
differentiation appears to be primarily related to increased A23187-responsiveness. In 
fact, the early (36 hr) increase in responsiveness to PMA preincubation may also be due 
to development of the ability to increase [Ca2+]i, thus translocating PKC as well as 
cPLAj.
In summary, we have demonstrated that DMSO-differentiation of U937 cells 
induces an enhanced capacity to mobilize arachidonate in response to calcium ionophore 
A23187 stimulation. The arachidonate mobilizing activity in differentiated U937 cells is 
consistent with observed characteristics reported for cPLAj from both differentiated and 
undifferentiated cells in vitro. However, in intact cells, this activity is only weakly 
detectable prior to DMSO-differentiation. Although both increased calcium and 
phosphorylation regulate the activity of cPLA^ in vitro, our results suggest that a
calcium transient is a necessary prerequisite for in situ arachidonate mobilization. A 
differentiation-induced alteration in intracellular free calcium dynamics may regulate 
differentiation-induced mobilization of arachidonate in response to A23187 and PMA. 
Further studies, presented in Chapter 4, were designed to dissect the role of intracellular 
calcium in mobilization of arachidonate in U937 cells.
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CHAPTER 4
ARACHIDONATE MOBILIZATION IS COUPLED TO DEPLETION OF 
INTRACELLULAR CALCIUM STORES AND INFLUX OF 
EXTRACELLULAR CALCIUM IN DIFFERENTIATED U937 CELLS.
4.1 Background
U937 cells contain high quantities of CPLA2, and are a standard source for 
isolation of functional enzyme (27-29). Nonetheless, we have found that 
undifferentiated U937 cells release little free arachidonate in response to stimulation 
with A23187. The results presented in Chapter 3 identify an A23187-stimulatable 
arachidonate mobilizing activity in differentiated U937 cells, consistent with 
characteristics reported for CPLA2 in vitro (sensitivity to low calcium and a preference 
for arachidonyl-containing phospholipid substrates). Given that undifferentiated cells 
contain functional CPLA2, the levels of which increase only slightly with differentiation 
(77-80), we reasoned that the increased A23187 responsiveness observed in 
differentiated cells must be due to induction of CPLA2 regulatory elements.
Two possible regulatory elements for cPLA2 are intracellular free calcium 
([Ca2+]j) levels and phosphorylation. In intact cells, cPLA2 is phosphoiylated in 
response to PMA, zymosan, and purinergic agonists (31, 33, 61). Although 
phosphorylation further increases the in vitro activity of CPLA2, an elevation in [Ca2+]i 
appears to be essential in activation of cPLA2 in situ (35, 62-64). Our previous work
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has shown that PMA alone, which causes phosphorylation of cPLA2  (22, 33, 31) is an 
insufficient stimulus for arachidonate mobilization in DMSO differentiated U937. 
Therefore, we reasoned that differentiation-induced alterations in [Ca2+]i dynamics could 
control arachidonate mobilization in U937 cells.
In non-electrically excitable cells such as U937, a principal mechanism for 
elevation of [Ca2+]i is through the “capacitative” or “second messenger operated” 
calcium influx pathway described by Putney (85, 8 6 ). Activation of this pathway is 
initiated by receptor-ligand binding, involving either G-protein or tyrosine-kinase linked 
receptors (87). Receptor-ligand binding is then transduced into activation of 
phosphoinositide specific phospholipase C (PLC). PLC hydrolyzes phosphatidylinositol 
4,5-bisphosphate (PIP2), resulting in the formation of the second messengers 
diacylglycerol (DAG) and inositol 1,4, 5 trisphosphate (IP3) (87, 8 8 ). According to the 
capacitative model of Putney (85), IP3 binds to receptors on intracellular calcium stores, 
signaling release of calcium from these stores. An initial, rapid elevation of [Ca2+]i is 
produced. Depletion of store calcium results in the generation of a diffusible messenger 
or calcium influx factor (CIF), which directs the opening of “store operated channels” 
(SOC) or “second messenger operated” (SMOC) calcium channels in the plasma 
membrane (85, 86, 89). Influx of extracellular calcium through these channels and into 
the cytoplasmic compartment results in a sustained phase of elevated [Ca2+]i. Therefore, 
the capacitative signal is biphasic, consisting of two components. The first is an 
elevation of [Ca2+]; due to intracellular store depletion. This is followed by a second 
phase consisting of influx of extracellular calcium, which is regulated by the filling state 
of intracellular stores.
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The precise location of intracellular calcium stores is presently unclear. 
Subcellular fractionation studies revealed that the location of DVresponsive organelles 
did not correlate with markers for the plasma membrane, endoplasmic reticulum, 
mitochondria, golgi, or other known organelles (90). In bovine endothelial cells, the IP3 
receptor was immunolocalized to granular-like structures in the perinuclear region of 
the cells (91). Lew (92) reported that the IP3 responsive organelles in the neutrophil 
appeared to be of a unique type, termed the “calciosome”, which is considered to be a 
modified portion of the endoplasmic reticular network (93).
The precise nature of the CIF is also unknown. There are two basic hypotheses 
regarding the nature of the intracellular signal that results in store-controlled calcium 
influx. The first involves release of a diffusible second messenger upon depletion of 
intracellular calcium stores, which results in the opening of plasma membrane calcium 
influx channels (SOC). The store-controlled generation of a diffusible messenger has 
recently been demonstrated, and is thought to involve a 
phosphorylation/dephosphorylation reaction (89, 94). Alternatively, the CIF may 
represent a more a physical connection between calcium stores and calcium influx 
channels, in which empty stores induce some form of conformational change which is 
transmitted to plasma membrane channels by a direct coupling (86). Recent studies 
implicate involvement of a low molecular weight guanine nucleotide binding protein that 
may direct transport of vesicles containing calcium influx channels to the plasma 
membrane (95, 86).
The capacitative calcium influx pathway has been identified in U937, as well as 
other cell types (87, 96). Several CPLA2 activating ligands, such as thrombin (42), ATP
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(13, 33), prostaglandins (41, 43), PDGF (40), and histamine (97) also activate the 
capacitative pathway. We therefore chose to investigate the role of capacitative calcium 
entry as a differentiation-induced regulatory mechanism for CPLA2 in U937.
The studies described in the previous chapter utilized the calcium ionophore 
A23187 to elevate [Ca2+]i independent of receptor-mediated events. However, A23187 
elevates [Ca2+]j by both transport of extracellular calcium across the plasma membrane 
into the cytosol and by transport of calcium from intracellular stores into the 
cytoplasmic compartment (98). This dual action of A23187 makes it difficult, if not 
impossible, to separate elevations in [Ca2+]i due to influx calcium from those generated 
by depletion of intracellular stores. Therefore, many of the experiments in this chapter 
make use of the pharmacological agent thapsigargin (99). This terpene compound 
selectively inhibits the Ca2+-ATPase located on IP3 sensitive intracellular stores. The 
Ca2+-ATPase of the plasma membrane is not affected. In the absence of agonist 
stimulation, there is a small but continuous leakage of calcium from the stores to the 
cytoplasm. The Ca2+-ATPase pumps calcium back into the stores, maintaining their 
filled state (88). By inhibition of the Ca2+-ATPase, thapsigargin treatment results in 
depletion of intracellular stores and activation of the capacitative pathway, independent 
of plasma membrane receptor-mediated events (99).
In the present chapter, we demonstrate that differentiated U937 cells attained 
higher elevations of [Ca2+]j in response to both thapsigargin and A23187, consistent 
with enhancement of capacitative calcium entry. Differentiation induced alterations in 
the size of intracellular calcium stores, and the characteristics of plasma membrane 
calcium influx channels. Mobilization of arachidonate in differentiated cells was coupled
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to activation of the capacitative pathway. An initial arachidonate mobilizing activity 
was identified during depletion of intracellular calcium stores, prior to capacitative 
calcium influx. Results suggest that this initial release of arachidonate may be involved 
in the generation of a CIF that regulates the opening of plasma membrane calcium influx 
channels. A second phase of arachidonate mobilization was coupled to influx of 
extracellular calcium, and resulted in maximal levels of arachidonate release. PMA pre- 
incubation was without effect on either arachidonate release or [Ca2+]i elevations 
resulting from depletion of intracellular calcium stores. However, PMA pre-incubation 
potentiated influx of extracellular calcium and arachidonate release coupled to this phase 
of the capacitative pathway. Based on these results, we propose a model for regulation 
of cPLA2-mediated arachidonate release in differentiated U937.
4.2 Results
4.2.1 Effects of A23187 on intracellular free calcium elevations in differentiated 
and undifferentiated U937 cells.
Elevations in [Ca2+]; stimulated by increasing concentrations of A23187 were 
measured in both differentiated and undifferentiated cells (Figure 10). These results 
confirm that A23187 concentrations of < 1 pM do, if fact, produce [Ca2+]i levels within 
the sub-micro to micromolar range within which CPLA2 in known to translocate in vitro.
The results in Figure 10 also indicate that differentiated U937 cells attained 
significantly higher elevations of [Ca2+]i in response to A23187 than undifferentiated 
cells. PMA pre-incubation further increased A23187-stimulated elevations of [Ca2+]i in
45
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
FIGURE 10
EFFECTS OF DMSO DIFFERENTIATION ON A23187-STEVTULATED
ELEVATION OF ICA2+]i .
Undifferentiated or differentiated U937 cells were loaded with Fura-2 as described in 
Methods 2.9. Cells were stimulated with A23187 at the concentrations indicated and 
[Ca2+]i was determined as described (Methods 2.9). For PMA pre-incubation, aliquots 
of Fura-2 loaded cells were incubated with 10 nM PMA for 10 minutes prior to 
measurement of [Ca2+] i . Results represent the mean ± SE of the maximum elevations 
of [Ca2+]i attained in response to the indicated concentration of A23187 (n=8-10)
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differentiated cells by 50 - 100% over the concentration range of 0.01 - 1 . 0  pM 
A23187. PMA was without effect in undifferentiated cells. The effects of PMA on 
A23187-stimulated elevations in [Ca2+]; were essentially abolished (>95%) by 
staurosporine (1 pM), suggestive of PKC mediated events (data not shown).
4.2.2 Effects of depletion of intracellular calcium stores on [C a2+]j elevations in 
differentiated and undifferentiated U937 cells.
A23187 elevates [Ca2+]i by direct transport of calcium across the plasma 
membrane, as well as across the membranes of intracellular stores, into the cytoplasmic 
compartment (81). It has been suggested that low doses of ionophore (< 1 pM) elevate 
[Ca2+]i primarily by depletion of intracellular stores and activation of capacitative 
calcium influx (100). We therefore sought to examine whether the A23187-stimulated 
elevations in [Ca2+]i observed in differentiated U937 were due to increased activation of 
capacitative calcium entry. For these experiments, cells were challenged with 
thapsigargin, which results in intracellular calcium store depletion and activation of the 
capacitative calcium influx pathway (99). Undifferentiated cells responded to 1 pM 
thapsigargin with a weak elevation of [Ca2+] i , from a basal level of 55 nM to 216 nM 
(Figure 11). In contrast, differentiated cells exhibited a dramatic 14 to 18 fold increase 
over basal levels of [Ca2+]i in response to thapsigargin (0.01-1.0 pM). Thus, the 
capacitative pathway was, indeed, enhanced by DMSO-differentiation.
A 10 minute pre-incubation of differentiated or undifferentiated cells with 10 nM 
PMA essentially doubled basal levels of [Ca2+]i (Figure 11); from 55 to 114 nM in 
undifferentiated cells, and from 48 to 106 nM in differentiated cells. PMA pre-
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FIGURE 11
EFFECTS OF DMSO-DIFFERENTIATION ON THAPSIGARGIN- 
STIMULATED ELEVATIONS OF [CA2+]i IN U937 CELLS.
Cells were prepared and [Ca2+]j was measured as described in Figure 10. The indicated 
concentrations of thapsigargin were added in a volume of 2.5 pi DMSO. Results 
represent the mean + SE of the maximum elevations of [Ca2+] attained in response to 
the indicated concentration of thapsigargin (n=6-8).
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incubation weakly inhibited thapsigargin-stimulated elevations of [Ca2+]i in 
undifferentiated cells at only at higher thapsigargin concentrations (0.1-1.0 pM). In 
contrast, PMA pre-incubation potentiated thapsigargin (0.1-1.0 pM)-stimulated 
elevations of [Ca2+]i in differentiated cells, but not as dramatically as the response seen 
with PMA + A23187 (Figure 10).
Although the PMA effect on maximum elevations of [Ca2+]i was weak, PMA 
dramatically increased the rate of [Ca2*]j elevation (Figure 12). Without PMA pre­
incubation, differentiated U937 cells attained maximal [Ca2+]i levels within 4-5 minutes 
of thapsigargin addition. There was a lag period of approximately 2 minutes after 
thapsigargin addition, during which elevation of [Ca2*]i was minimal. This lag period is 
not unusual for thapsigargin (99). Once the Ca2*-ATPase is inhibited, the intracellular 
stores are depleted by slow leakage. Thus, the lag period represents the time required 
for significant store depletion to occur, and capacitative calcium influx to begin 
(illustrated in Figure 12 by the rapid increase in [Ca2*]j which begins at approximately 
190-200 seconds). However, when differentiated U937 cells were pre-incubated with 
PMA, the lag period was reduced by 30 - 45 seconds. The effects of PMA were 
inhibited (>90%) by 1 pM staurosporine (data not shown).
4.2.3 Differentiated and undifferentiated U937 cells have dissimilar
capacitative calcium entry pathways.
Further experiments were conducted to dissect the respective roles of the two 
phases of the [Ca2+]i elevation associated with capacitative influx, and examine 
differentiation-induced alterations. The relative size of intracellular free calcium stores in
49
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FIGURE 12
EFFECTS OF PMA ON THAPSIGARGIN-STIMULATED ELEVATIONS OF 
[CA2+]i IN DIFFERENTIATED U937 CELLS
Cells were prepared as described in Figure 10. After Fura-2 loading, differentiated cells 
were incubated with 10 nM PMA for 10 minutes. After pre-incubation, cells were 
stimulated with thapsigargin (1 jaM) and [Ca2+]i was measured as described in Methods 
2.9. The tracing shown is representative of at least 10 similar measurements performed 
on different days.
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differentiated and undifferentiated cells was determined by thapsigargin stimulation in 
Ca2+-ffee medium. Under these conditions, any observed increases in [Ca2+]i could only 
be generated from emptying of the intracellular stores. Incubation of differentiated cells 
in calcium free medium inhibited 70-85% of the thapsigargin-stimulated elevations of 
[Ca2+]i (Figure 13) However differentiated cells did exhibit a small but significant 
increase in [Ca2+]; in response to 1 pM thapsigargin (approximately 2 -2.5 fold over 
basal levels). In contrast, when undifferentiated cells were incubated in calcium-free 
medium, 95-98% of the response to 1 pM thapsigargin was inhibited. Similar results 
were observed when cells were incubated in medium containing Ca2+, and extracellular 
calcium was chelated by addition of 1.1 mM EGTA (Figure 14). These results indicate 
that either the intracellular calcium stores, or the filling state of the stores, is altered 
upon differentiation.
Additional experiments were conducted to characterize capacitative influx of 
extracellular calcium in differentiated and undifferentiated cells. As the maximal 
thapsigargin-stimulated elevations in [Ca2+], are higher in differentiated cells, we 
reasoned that differentiation might simply induce more capacitative channels. Quite 
unexpectedly, the results shown in Figure 14 indicate that the characteristics of the 
calcium influx channels appear to be altered with differentiation. Econazole (2 pM), an 
inhibitor of capacitance calcium influx in many cell types (98), did not inhibit 
thapsigargin stimulated elevations in [Ca2+]i in undifferentiated cells. In contrast, 2 pM 
econazole inhibited 44-49% of the thapsigargin-stimulated elevations in [Ca2+]i in 
differentiated cells. A second inhibitor of capacitance calcium entry channels, 
SKF96365 (101) also failed to inhibit thapsigargin induced calcium influx in
51
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FIGURE 13
EFFECTS OF DIFFERENTIATION ON THE SIZE OF INTRACELLULAR
CALCIUM STORES.
Differentiated and undifferentiated cells were loaded with Fura-2 as described in 
Methods 2.9. After loading, cells were washed three times with Ca2+-free PBS, and 
resuspended in the same buffer. Thapsigargin (1 |iM) was added as indicated by the 
arrow and [Ca2+];. was measured as described. The tracings shown are representative of 
at least 5 similar experiments performed on different days.





















Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
FIGURE 14
E FFE C T S O F  V A RIO U S IN H IB IT O R S O F CAPACTTATTVE C A L C IU M  
IN FLU X  O N  TH A PSIG A R G IN -STIM U LA TED  ELE V A T IO N S O F  [C A 2+] i  IN  
U N D IFFER EN TIA TED  (PA N EL A) AND D IFFE R E N T IA T E D  (PA N EL B ) U937
CELLS.
Differentiated (filled bars) or undifferentiated cells (open bars) were loaded with Fura-2 
as described in Methods 2.9. For Ca2+ free experiments, cells were prepared as 
described in Fig 13. Aliquots (0.5 ml) containing 106 cells were added to the 
spectrofluorometer cuvette and measurement of [Ca2+]i was initiated. EGTA (1 mM), 
Econazole (2pM) , Ni2+(5 mM), and SKF96365 (1 pM) were added in volumes of 2.5 
pi. 1 pM thapsigargin was then added, and [Ca2+]; was measured for an additional 10 
minutes. The maximum elevation in [Ca2+]i in response to thapsigargin was determined 
for each treatment. Results were normalized to the maximum [Ca2+]i level achieved by 
lpM thapsigargin (215 +45 nM in undifferentiated cells; 705 + 127 nM in differentiated 
cells) and represent the percentage of the 1 pM thapsigargin response. Data shown 
represents the mean ± SE of 3-5 separate experiments.
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undifferentiated cells. However 1 pM SKF96365 resulted in an 80% inhibition of 
thapsigargin-stimulated elevations in [Ca2+]i in differentiated U937 cells. Nickel (5mM), 
which also blocks calcium influx channels (88), was also a somewhat more effective 
inhibitor of calcium influx in differentiated cells. Taken together, these results suggest 
that thapsigargin-induced capacitative calcium influx occurs through dissimilar channels 
or is under altered regulatory control in differentiated and undifferentiated U937.
4.2.4 Differentiation induced changes in the capacitative calcium entry pathway 
are consistent with differentiation induced changes in arachidonate release.
If the activation of cPLA2 and subsequent arachidonate release are, indeed, 
regulated by development of a specific differentiation-induced capacitative calcium entry 
pathway in U937, then stimulation of differentiated U937 with thapsigargin should also 
activate arachidonate release. Figure 15 demonstrates that thapsigargin produced a 
dose dependent increase in arachidonate release in differentiated U937 cells. PMA pre­
incubation potentiated thapsigargin-stimulated arachidonate release 2-3 fold, similar to 
the response seen using A23187 as stimulus (Figure 4, Chapter 3). Quite strikingly, 
thapsigargin or PMA + thapsigargin were completely ineffective at stimulating even a 
slight arachidonate release in undifferentiated cells. Thus, differentiation induced 
arachidonate mobilization appears to be coupled to the differentiation-induced 
development of a capacitance calcium influx pathway.
This coupling is particularly evident when A23187-stimulated effects on [Ca2+]j 
and arachidonate release are compared to thapsigargin-stimulated effects. A23187 (0.1 
pM) produced a [Ca2+]i elevation of 2200 nM in differentiated U937 (Figure 16B).
54
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FIGURE 15
EFFECTS OF THAPSIGARGIN ON ARACHIDONATE MOBILIZATION IN 
DIFFERENTIATED AND UNDIFFERENTIATED U937 CELLS.
U937 cells were differentiated and radiolabeled as described in Sections 2.2-2.3. 
Arachidonate mobilization in response to thapsigargin stimulation was measured as 
described in Section 2.4. Release of radiolabeled arachidonate is expressed as a 
percentage of the total cellular incorporated radioactivity. Data points represent mean ± 
SE of 3-4 separate experiments performed in duplicate.
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FIGURE 16
COMPARISON OF THAPSIGARGIN AND A23187-STIMULATED 
ELEVATIONS IN [Ca2+]( AND ARACHIDONATE MOBILIZATION IN
DIFFERENTIATED U937.
Figure 16A is a composite of Figures 4 and 15, and compares A23187-stimulated 
arachidonate mobilization to thapsigargin-stimulated arachidonate mobilization. Figure 
16B is a composite of Figures 10 and 11, and represents a comparison of A23187 and 
thapsigargin-stimulated elevations in [Ca2+]i
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Thapsigargin (0.1 pM) produced a [Ca2+]i elevation of only 1000 nM (Figure' 16B). If 
CPLA2 were solely dependent on [Ca2+]i, one would expect that A23187 would also 
produce greater arachidonate release than thapsigargin. However at concentrations of
0.1-1 pM, thapsigargin stimulation resulted in a 7-12 % (respectively) release of total 
incorporated arachidonate (Figure 16A). A23187 (0.1-1.0 pM) produced the same 
levels of arachidonate release. During A23187 stimulation, a portion of the elevated 
intracellular calcium is due to direct transport of calcium across the plasma membrane 
by A23187. Likewise, a portion of the A23187 effect is due to depletion of intracellular 
calcium stores and activation of capacitative influx. These results suggest that only the 
latter mechanism of [Ca2*]i elevation, (depletion of stores followed by capacitative 
calcium entry) is coupled to activation of arachidonate release. Elevation of [Ca2+]i by 
means other than the capacitative pathway, such as direct ionophore mediated transport 
of extracellular calcium across the plasma membrane, does not appear to activate 
arachidonate release in these cells.
To further support the role of extracellular calcium influx through store operated 
calcium channels in arachidonate mobilization, Sr2+ was utilized as a surrogate ion for 
calcium. In many biochemical processes, calcium can be replaced by Sr2+ without 
compromise of biological function (74-76). In the absence of extracellular calcium, Sr2+ 
is transported through store operated calcium influx channels in response to a stimulus
(76). As cells contain little or no intracellular Sr2+, changes in Fura 2 fluorescence in the 
presence of extracellular Sr2+ (and absence of extracellular calcium) would indicate 
influx of extracellular cation. The results shown in Figure 17A demonstrate that 
thapsigargin stimulated influx of Sr2+ from the extracellular medium in both
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FIGURE 17
EFFECTS OF EXTRACELLULAR Sr*+ ON THAPSIGARGIN-STIMULATED 
ELEVATIONS OF INTRACELLULAR DIVALENT CATION AND 
ARACHIDONATE MOBILIZATION IN DIFFERENTIATED AND 
UNDIFFERENTIATED U937 CELLS.
For measurement of intracellular free Sr2+ (Figure 17A), cells were loaded with Fura-2 
as described in Methods 2.9. After loading, cells were resuspended in Ca2+-free PBS as 
described in Figure 13. Aliquots of cell suspension containing 106 loaded cells were 
added to the spectrofluorometer cuvette and measurements were initiated. Sr2+ (1 mM) 
was added in a volume of 2.5 jliI PBS/albumin/glucose, followed by thapsigargin (1 
pM). Intracellular free Sr2+ was calculated as described in Methods 2.9. Results 
represent the mean + SE of three separate experiments.
For measurement of thapsigargin stimulated arachidonate release in the presence of 
extracellular Sr2+, (Figure 17B), cells were radiolabeled as described in Methods 2.3. 
Following labeling, cells were washed twice in Ca2+-free PBS and resuspended in the 
same. Sr2* (1 mM) was added prior to thapsigargin challenge. Thapsigargin stimulation 
and quantitation of released radiolabel were as described in Section 2.4. Results 
represent the mean + SE of three separate experiments performed in duplicate.
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differentiated and undifferentiated cells. Consistent with effects observed with calcium, 
differentiated cells achieved significantly higher elevations of intracellular free Sr2* than 
did undifferentiated cells. Furthermore, this elevation of intracellular free Sr2* was 
coupled to arachidonate release in differentiated, but not undifferentiated cells (Figure 
17B). Thapsigargin-stimulated arachidonate mobilization in the presence of 
extracellular Sr2* was similar to that observed with Ca2+ as extracellular divalent cation 
(Figure 15). This suggests that arachidonate release in differentiated U937 is coupled to 
divalent cation influx through a differentiation-induced capacitative channel.
4.2.5 Arachidonate release is coupled to elevations in [Ca2+]i generated from 
store depletion, as well as through store operated capacitative influx channels.
If arachidonate release is coupled solely to capacitative calcium influx in 
differentiated U937 cells, then inhibition of capacitative influx should have similar 
effects on arachidonate mobilization. Differentiated U937 cells were stimulated with 
thapsigargin in the presence of various inhibitors of capacitance calcium entry as shown 
in Figure 18. Stimulation of differentiated cells in medium containing calcium chelated 
with EGTA, or in calcium free medium, resulted in inhibition of 70-85% of thapsigargin 
induced arachidonate release. Thus, arachidonate release is primarily coupled to influx 
of extracellular calcium. However, one cannot ignore the fact that significant 
thapsigargin-stimulatable arachidonate release (15-20% of that observed in response to 
1 pM thapsigargin in calcium-containing medium) remains, even after removal of all 
extracellular calcium. This suggests that a portion of the total arachidonate release 
observed may be due to [Ca2+]i elevations resulting directly from store depletion. In the
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FIGURE 18
EFFECTS OF INHIBITION OF CAPACITATIVE CALCIUM INFLUX ON 
THAPSIGARGIN-STIMULATED ARACHIDONATE RELEASE IN 
DIFFERENTIATED U937.
Cells were radiolabeled and stimulated ± PMA as described in Section 2.4. 
PBS/albumin/glucose solutions of EGTA (ImM), Ni2+ (5mM), SKF96365 (1 pM), and 
econazole (2 pM) were added during the pre-incubation period. For Ca2+-free 
experiments, cells were radiolabeled and washed twice in Ca2+'free PBS and 
resuspended in the same. Results were normalized to the arachidonate release 
stimulated by 1 pM thapsigargin in Ca2+ containing medium (14.19 + 1.67 % of total 
incorporated radiolabel), and represent mean ± SE for 3-5 separate experiments 
performed in duplicate






u i  IS
d l  DtFTEBENTUTKD U937 
m  DUTKRENTUTd CELLS + PIU
PBS THAPS - C a a+ +EGTA + N I 8+ +SKP +KC0N 
1 H U  I v a i l  6 v a i l  1/*U SpU
FIGURE 18
60
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
absence of extracellular calcium, PMA potentiation of thapsigargin-induced 
arachidonate release was weak. Thus, PMA potentiation of arachidonate release 
appears to be primarily dependent on that arachidonate release associated with influx of 
extracellular calcium (Figure 18).
Nickel (5mM) which physically blocks calcium entry though plasma membrane 
channels, also blocked arachidonate release, but not as effectively as it blocked 
elevations in [Ca2+]i (compare Figures 18 & 14). Similar results were observed with 
SKF96365, which inhibited only 50% of the thapsigargin-stimulated arachidonate 
release (Figure 18) at concentrations that blocked 75-80% of the thapsigargin- 
stimulated elevation of [Ca2+]i (Figure 14). Both these inhibitors act at the level of the 
store-operated channel. These results suggest an initial release of arachidonate occurs 
proximal to the opening of plasma membrane calcium influx channels. This is further 
supported by experiments in which econazole was used as an inhibitor. Econazole, at 
the same concentration that produced 50% inhibition of capacitance calcium influx, 
resulted in a 10-20% increase in arachidonate mobilization. It has been reported that 
econazole blocks capacitative calcium entry by inhibition of a cytochrome P450 
dependent step integral to the opening of plasma membrane calcium channels (98). This 
suggests that initiation of arachidonate release may lie upstream of P450-mediated 
capacitance calcium influx, and may be controlled by calcium mobilization from the 
stores themselves.
PMA potentiation of thapsigargin-simulated arachidonate release was effectively 
blocked by inhibitors of calcium influx. This suggests that PKC may potentiate 
arachidonate release at the level of the calcium influx channel.
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4.2.6 The time course of thapsigargin-stimulated arachidonate release correlates 
with the time course of thapsigargin-stimulated elevations in [Ca2+]i.
Arachidonate release appears to be coupled to both phases of capacitative 
calcium entry. Therefore, thapsigargin-stimulated release of arachidonate should follow 
a time course similar to thapsigargin-stimulated elevations of [Ca2+]i. Initially, [Ca2+]j 
rose slowly in response to thapsigargin stimulation (Figure 19A). This slow increase 
continued until approximately 150 seconds, at which time [Ca2+]i reached 110-125 nM. 
This was consistent with thapsigargin-induced elevations in [Ca2+]j due to depletion of 
stores alone (Figure 13). This phase was followed by a rapid increase in [Ca2+]i 
consistent with capacitative influx (Figure 19A). Maximal elevations of [Ca2+]i were 
achieved by 300 seconds post thapsigargin. The thapsigargin stimulated time course of 
arachidonate release is shown in Figure 19B. The most striking finding is that 
arachidonate release is enhanced 2 fold over basal levels within 30 seconds of addition 
of thapsigargin, as intracellular calcium stores are undergoing depletion. A linear 
release of arachidonate continued through 300 seconds post-thapsigargin, at which time 
arachidonate release was maximal. Stimulation for longer time periods (up to 10 
minutes) did not result in further increases in arachidonate release (data not shown). 
Thus, arachidonate mobilization occurs as the intracellular calcium stores are being 
depleted, and continues until maximal elevations of [Ca2+]i are attained.
PMA pre-incubation raised initial basal [Ca2+]i levels (Figure 19A, zero time 
point). The enhanced elevations of [Ca2+]i observed in PMA + thapsigargin treated cells 
appear to be additive to that of thapsigargin induced elevations of [Ca2+]; for the first 
150 seconds of stimulation. Thus, PMA pre-incubation does not
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FIGURE 19
TIME COURSE OF THAPSIGARGIN-STIMULATED ELEVATIONS OF 
[CA2+h AND ARACHIDONATE RELEASE IN DIFFERENTIATED U937
CELLS.
In panel A, [Ca2+]j was measured in Fura 2 loaded cells + PMA pre-incubation as 
described in Methods 2.9. In panel B, arachidonate mobilization was stimulated as 
described in Methods 2.6. Reactions were stopped at the indicated time intervals after 
thapsigargin stimulation, by addition of methanol. Cells plus incubation media were 
extracted and chromatographed in petroleum ether/diethyl ether/glacial acetic acid 
(82:18:1) as described in Methods 2.6. Released arachidonate was quantitated using a 
Bioscan radioactivity scanner. All results represent the mean ± SE of 3 experiments 
performed in duplicate
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seem to directly effect thapsigargin-induced intracellular calcium store depletion. PMA 
did, however, significantly potentiate the sustained phase of capacitative calcium influx. 
Similar effects were observed with the time course of PMA + thapsigargin stimulated 
arachidonate release (Figure 19B). Arachidonate mobilization coupled to intracellular 
calcium store depletion was not affected by PMA pretreatment. However, arachidonate 
release coupled to influx of extracellular calcium was significantly potentiated by PMA. 
This suggests differential regulation of CPLA2, dependent on either the source of 
intracellular calcium, or on an actual threshold level of [Ca2+]i above which PMA 
potentiates arachidonate release.
Further evidence for this differential regulation is presented in Figure 20. A plot 
of arachidonate release as a function of the change in [Ca2+]i demonstrates that in the 
absence of PMA pretreatment, the relationship is approximately linear during store 
depletion and calcium influx (open circles). Thus, release of arachidonate correlates well 
with [Ca2+]i elevations. In PMA pre-treated cells, thapsigargin-stimulated arachidonate 
release is linear with respect to [Ca2*],- elevation up to a change in [Ca2+]i of 
approximately 75 nM. This change in [Ca2+]i is approximately equivalent to that 
attained by depletion of intracellular calcium stores alone. Thus, it appears that PMA 
potentiation of arachidonate release is observed during calcium influx, downstream of 
store depletion.
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FIGURE 20
THAPSIGARGIN-STIMULATED ARACHIDONATE RELEASE AS A
FUNCTION OF [Ca2+]i.
Data for thapsigargin-stimulated arachidonate release presented in Figure 19 is graphed 
as a function of change in [Ca2+]i
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4.2.6 Thapsigargin stimulated effects on [Ca2+]i elevation and arachidonate 
mobilization are blocked by PLA2 inhibitors
The previous results suggest that arachidonate release is coupled to both phases 
of the capacitative calcium entry pathway; store depletion and influx of extracellular 
calcium. Furthermore, arachidonate release preceded opening of capacitative calcium 
entiy channels. We therefore sought to examine whether inhibition of arachidonate 
release could inhibit capacitance calcium influx. For these experiments, differentiated 
U937 cells were pre-incubated with either NDGA or PGBx. PGBx is an oligomer of 
prostaglandin B, which inhibits cPLA2 (and sPLA2) in vitro, and inhibits arachidonate 
release in U937 and other cells (49). PGBx inhibited thapsigargin-stimulated elevations 
in [Ca2+]j as well thapsigargin-stimulated mobilization of arachidonate.
NDGA is a non-metabolizable substrate analog which inhibits 5-lipoxygenase 
and P450 pathways of the arachidonate cascade (72). U937 cells lack a 5-lipoxygenase
(77). Therefore, the expected effects of NDGA in U937 would be primarily on a P450 
system involved in the metabolism of free arachidonate. Like PGBx, NDGA also 
inhibited thapsigargin induced elevations in [Ca2+]i (Figure 21). However, NDGA also 
inhibited thapsigargin-stimulated arachidonate mobilization. This indicates that although 
NDGA may inhibit cytochrome P450-mediated arachidonate metabolism in some cells, 
it can also act as a cPLA2 inhibitor in differentiated U937. Taken together, these results 
suggests that released arachidonate and/or a metabolite thereof, may participate in 
regulation of capacitative calcium influx.
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FIGURE 21
EFFECTS OF PGBx AND NDGA ON THAPSIGARGIN-STIMULATED 
ELEVATIONS OF [Ca2+]i AND ARACHIDONATE MOBILIZATION IN 
DIFFERENTIATED U937 CELLS.
For arachidonate release (filled bars) cells were prepared, radiolabeled and stimulated as 
described in Methods 2.4. PGBx and NDGA were added during the pre-incubation 
period, as described. Results were normalized to the arachidonate release stimulated by 
1 pM thapsigargin. For measurement of [Ca2+]i, cells were loaded with Fura-2 and 
calcium was measured as described in Methods 2.9. NDGA or PGBx were added 3 
minutes prior to addition of thapsigargin, and [Ca2+]i was monitored for an additional 10 
minutes. Results are normalized to the maximum [Ca2+]i elevation obtained in response 
to 1 pM thapsigargin. Result represent mean ± SE of at least 3 separate experiments.
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4.3 DISCU SSIO N
In Chapter 3, we demonstrated that differentiation of U937 cells induced 
significant A23187-stimulatable arachidonate release, not present in undifferentiated 
cells. The present chapter demonstrates that this enhanced capacity to release 
arachidonate in response to a calcium signal is coupled to differentiation-induced 
development of a capacitative calcium influx pathway. Furthermore, our data suggests 
that release of arachidonate may contribute to the activation of this calcium influx 
pathway. Based on the results presented here, a model for CPLA2  regulation is 
proposed in Figure 22. According to this model, differentiation induces alterations in 
both the size of thapsigargin-stimulatable intracellular calcium stores, and the 
characteristics of store or second messenger operated calcium influx channels 
(SOC/SMOC). Stimulation of differentiated U937 cells with thapsigargin results in an 
initial release of calcium from intracellular stores, causing a localized increase in calcium 
near the membrane of intracellular stores. Thus, CPLA2 translocates to the membranes 
of intracellular stores and initiates mobilization of arachidonate. Released arachidonate 
and/or a metabolite thereof may participate in generation of a second messenger or CIF, 
which regulates opening of SOC/SMOC in the plasma membrane. Influx of 
extracellular calcium through SOC results in a localized calcium increase at the plasma 
membrane, thereby recruiting more CPLA2 to this subcellular location.
Several lines of evidence support CPLA2 as the enzyme mediating thapsigargin- 
stimulated release of arachidonate. First, as the 14 kDa secretory PLA2 requires 
millimolar calcium for catalysis, it does not appear likely that it is active under the sub­
micromolar levels of [Ca2+]i we observe in these experiments. Second, strontium was
68
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FIGURE 22
REGULATION OF cPLA2 IN DIFFERENTIATED U937 CELLS.
Thapsigargin (THAPS) inhibits the calcium pump located on the endoplasmic reticulum 
(ER) or possibly nuclear (NUC) membrane. Calcium then leaks into the cytoplasm 
through a channel, possibly the IP3 receptor/channel. The local high concentration of 
Ca2+ generated near this channel causes translocation and activation of CPLA2  (ACT 
cPLA2), to the calcium store membrane, generating free arachidonic acid (AA). AA 
could then be converted, via cytochrome P450, to a calcium influx factor (CIF) which 
could then activate the store or second messenger operated calcium influx channel 
(SOC/SMOC) located in the plasma membrane, allowing entry of calcium from the 
extracellular space into the cytoplasm. Alternatively, CIF may not be an arachidonate 
metabolite itself, but could be generated by activation of a low molecular weight 
GTPase by free arachidonic acid. The local high concentration of Ca2+ near the plasma 
membrane calcium channel would then translocate and activate cPLA2 (ACT-cPLA2) to 
promote mobilization of AA at the plasma membrane
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capable of supporting arachidonate release in response to thapsigargin stimulation, to 
the same extent as that observed with calcium as extracellular divalent cation. In vitro, 
sPLA2 has an absolute requirement for calcium, and cannot utilize strontium for 
catalysis (102). However, cPLA2 is active in the presence of strontium (39). Third, 
results in Chapter 3 have previously demonstrated that arachidonate release in 
differentiated U937 cells exhibits a preference for arachidonate, consistent with the 
characteristics of cPLA2 activity. These results strongly suggest that arachidonate 
mobilization in response to thapsigargin stimulation is mediated by cPLA2.
Free arachidonate can also be generated by the combined actions of 
phospholipases C or D, and diglyceride lipase. However, thapsigargin treatment does 
not result in result in the generation of IP3, and therefore does not appear to activate 
PLC (14, 99). Furthermore, we do not observe any changes in the arachidonate 
labeling of the mono or diglyceride lipid fractions during the time course of thapsigargin 
stimulation (data not shown). Taken together, these results preclude a major role for 
PLC in thapsigargin-stimulated arachidonate mobilization in U937. Arachidonate 
mobilization was blocked by PGBx, an inhibitor of cPLA2. Phospholipase D is not 
inhibited by PGBx (49), suggesting that PLD does not contribute to thapsigargin- 
stimulated arachidonate release.
Figure 22 suggests that differentiation induces alterations in two primary 
components of capacitative calcium influx, the first of which is the intracellular calcium 
store. Our results indicate that differentiated cells have increased thapsigargin- 
stimulatable intracellular calcium stores, as compared to undifferentiated cells (Figure 
13). This could indicate that the physical size of intracellular calcium stores increases
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with differentiation. Alternatively, myeloid leukemia cells lines such as U937 are 
reported to contain high intrinsic levels of IP3, which decrease upon differentiation 
(103). Thus, the stores themselves may not necessarily be much larger, but may simply 
be “more full”.
The second component of capacitative calcium influx is the store or second 
messenger operated calcium influx channel (SOC/SMOC). Figures 11 and 14 suggest 
that capacitative calcium influx channels are either dissimilar or under altered regulatory 
control in differentiated and undifferentiated U937. Undifferentiated cells do appear to 
exhibit some elevations in [Ca2+]i in response to thapsigargin stimulation in calcium-free 
medium. Thus, the capacitative pathway does appear to function (although it is weak) 
in these cells. However, the small elevation in [Ca2+]i observed could also be due to 
influx of trace amounts of calcium remaining in the medium. Nevertheless, 
thapsigargin-stimulated elevations [Ca2+]i in undifferentiated cells is weak and is not 
coupled to mobilization of arachidonate. Differentiated cells however, respond to 
thapsigargin with dramatically enhanced levels of capacitative calcium influx.
Inhibitors of capacitative calcium influx channels, econazole and SKF96365, 
failed to block thapsigargin stimulated elevations of [Ca2+]i in undifferentiated cells. 
Both these compounds were quite effective at inhibition of capacitative calcium influx in 
differentiated cells. It has been suggested that econazole, at the concentrations used in 
these experiments, blocks capacitative calcium entry by inhibition of a cytochrome P450 
dependent step in the opening of store controlled capacitative channels (98). Lack of 
inhibition of thapsigargin-stimulated [Ca2+]i elevations by econazole suggests that this 
P450-mediated pathway may not contribute to calcium influx in undifferentiated cells.
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SKF96365 blocks capacitative calcium influx by physical association with calcium influx 
channels, inhibiting passage of the Ca2+ ion. The ineffectiveness of SKF96365 in 
undifferentiated cells suggests that the channel activated in these cells has a different 
physical conformation. Furthermore, PMA pre-incubation had contrasting effects on 
thapsigargin-stimulated influx in differentiated and undifferentiated U937 (Figure 11). 
In undifferentiated cells, PMA pre-incubation had a slight inhibitory effect on 
thapsigargin-induced elevations of [Ca2+]i. In contrast, PMA potentiated thapsigargin- 
stimulated [Ca2+]; elevations in differentiated cells. Staurosporine (1 pM) blunted these 
effects, which implies regulation via PKC. Thus, PKC activation had contrasting effects 
on capacitative calcium influx in differentiated and undifferentiated U937. This suggests 
the existence of either different PKC isoforms in differentiated and undifferentiated cells, 
or different calcium influx channels. Taken together with results from inhibitor 
experiments, this suggests that differentiation does not merely induce an increased 
number of capacitative calcium influx channels. Rather, it may induce either a dissimilar 
channel, or a structural alteration of an existing channel, thereby enhancing capacitative 
influx.
cPLA2 activity appears to be coupled to both phases of the capacitative 
pathway, store depletion and influx of extracellular calcium. Our observations indicate 
that significant thapsigargin-stimulated arachidonate release occurs even in the absence 
of extracellular calcium. This is consistent with observations in thrombin stimulated 
platelets, in which arachidonate release was increased 2-3 fold over basal levels even in 
the absence of extracellular calcium (45). Furthermore, inhibition of calcium entry by 
agents which block capacitative influx at the level of the calcium channel did not
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completely block arachidonate release. This suggests that elevations of [Ca2+]i resulting 
from store depletion can, indeed, result in mobilization of arachidonate. The time 
course of thapsigargin-stimulated arachidonate release further supports this point. 
Arachidonate release begins within 30 seconds of addition of thapsigargin. The rapid 
increase in [Ca2+],-, indicative of capacitative calcium influx, does not begin until 
approximately 150 seconds after thapsigargin addition (Figures 19A & 19B). Taken 
together, these results indicate that initial release of arachidonate appears to occur as 
intracellular calcium stores are undergoing depletion.
We suggest that the initial thapsigargin-stimulated arachidonate mobilizing 
activity occurs at the membrane of the intracellular stores. In the absence of 
extracellular calcium, the maximum elevation of [Ca2+]i attainable by depletion of the 
stores with 1 pM thapsigargin was approximately 120 nM. This concentration of 
[Ca2+]i is well below the reported threshold calcium concentration of 250 nM, at which 
CPLA2 appears to translocate to membrane substrates in vitro (22). However, Fura 2 is 
likely to be evenly distributed throughout the cytoplasm (88). Thus, measurements of 
[Ca2+]i represent an average calcium concentration throughout the cytoplasmic 
compartment. The actual concentration of free Ca2+ immediately surrounding the stores 
could possibly be much higher (88, 104). Thus, CPLA2 would be more likely to 
associate with membranes in the area of a localized increase in free calcium. In Swiss 
3T3 fibroblasts, chelation of intracellular free calcium with BAPTA or EGTA-AM failed 
to inhibit CPLA2 mediated arachidonate release, suggesting that localized increases in 
near-membrane calcium could control CPLA2 activity (40). Thus, during the initial 
phase of thapsigargin-stimulated arachidonate release, a localized increase of calcium at
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the store membrane may result in CPLA2 translocation to this membrane.
The fate of arachidonate generated during intracellular calcium store depletion is 
at present, unclear. It has been suggested that arachidonate and/or its metabolites may 
be associated with activation of capacitative calcium entry channels (12-14). As 
demonstrated in time course experiments, as well as in experiments utilizing inhibitors of 
capacitance entry channels, an initial phase of arachidonate release precedes influx of 
extracellular calcium. Of particular interest is the effect of econazole on arachidonate 
release. In differentiated U937, econazole effectively blocked capacitative calcium influx 
at its reported IC50 (100). However, the same concentrations of econazole stimulated 
release of arachidonate. Free arachidonate can be metabolized by several different 
pathways, one of which is a P450 mediated process resulting in the production of 
HETES and epoxide derivatives. If a P4S0 arachidonate metabolite were involved in 
activation of capacitative influx, then inhibition of P450 by econazole would block 
production of this metabolite and inhibit calcium influx. cPLA2-mediated release of 
arachidonate in response to intracellular calcium store depletion might be unaffected. 
Thus, the observed effects of econazole on [Ca2+]i and arachidonate release suggest 
activation of capacitative influx by a P450 arachidonate metabolite. Recent evidence 
suggests that a non-cyclooxygenase metabolite of arachidonate regulated agonist- 
induced capacitative calcium influx in thyroid FRTL-5 cells (13). Additionally, 
exogenous arachidonate activated calcium influx in several cell lines (12, 14). A GTP 
dependent step in the capacitative calcium entry pathway has recently been identified 
(86, 95), which is dependent on hydrolysis of GTP to GDP. Arachidonate has been 
reported to participate in regulation of GTPase activating proteins (17-19, 105). Thus,
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there is evidence that arachidonate and/or its metabolites can participate in activation of 
capacitative calcium entry at several stages.
The second phase of the capacitative calcium influx pathway consists of the 
influx of extracellular calcium through store controlled plasma membrane channels. Our 
results suggest that arachidonate mobilization is also coupled to influx of extracellular 
calcium. Removal of extracellular calcium from the medium, inhibited 70-85% of 
thapsigargin-stimulated arachidonate release (Figures 13 & 18). Inhibition of 
capacitative calcium influx channels by nickel and SKF96365 produced similar effects. 
As depicted in the model in Figure 22, influx of calcium through plasma membrane 
channels would cause an increase in [Ca2+]u with local elevated levels at the plasma 
membrane (104). This local increase in calcium could then recruit CPLA2 to the plasma 
membrane. As these calcium concentrations are possibly even higher than those seen 
due to store depletion, arachidonate release would be even more rapid, as more CPLA2  
is recruited to this subcellular location.
PMA pre-incubation potentiated thapsigargin-stimulated calcium influx, as well 
as arachidonate release. However, PMA potentiation of arachidonate mobilization was 
only observed during the calcium influx phase of the thapsigargin response (Figs 19 & 
20). PMA did not effect arachidonate release associated with [Ca2+]i elevation due to 
store depletion. PMA effects were inhibited by staurosporine, suggestive of PKC 
mediated events. PMA induces phosphorylation of CPLA2 in situ, which enhanced in 
vitro activity of the partially purified enzyme (33, 61). Thus, PMA may enhance 
arachidonate release via PKC mediated phosphorylation cPLA2 itself. Additionally, our 
observations indicate that PMA may enhance capacitative calcium influx itself, resulting
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in increased [Ca2+]j for CPLA2 translocation. This elevation in [Ca2+]i alone may account 
for the increased arachidonate mobilization observed in PMA pre-incubated cells. Thus, 
PKC may have a dual role in regulation of arachidonate release. It may have effects on 
calcium influx, as well as on CPLA2 activity directly. Alternatively, there may be some 
threshold [Ca2+]j, above which PMA effects on arachidonate mobilization are observed. 
Regardless of the specific mechanism involved, PMA potentiation o f thapsigargin- 
stimulated arachidonate release only occurred during capacitative influx, suggesting that 
PKC mediated events lie downstream of calcium store depletion and initial release of 
arachidonate.
The proposed model studies suggests that the subcellular localization o f cPLAz 
is regulated by localized increases in [Ca2+]i. Thus, CPLA2 may be regulated by calcium 
dependent “compartmentalization”. Actual physical compartmentalization of enzymatic 
activity, as evidenced by confinement of various enzymes to specific membrane bound 
organelles, provides discrete areas dedicated to specific enzymatic processes. In the 
case of CPLA2, compartmentalization may be dependent on the free calcium 
concentration of the membrane microenvironment. This may assist in recruiting CPLA2 
to specific subcellular locations, thereby directing subsequent metabolism of 
arachidonate. For example, localization at the intracellular store membrane may favor 
metabolism by a P450 dependent pathway resulting in opening of capacitative calcium 
entry pathways. Likewise, localization of the enzyme to the nuclear membrane in 
conjunction with 5-lipoxygenase activating protein (106) may favor leukotriene 
production.
In summary, the results presented in this chapter demonstrate that DMSO
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differentiation of U937 cells induces an enhanced capacitative calcium influx pathway. 
In differentiated cells, cPLA2 is closely coupled to both phases of capacitative calcium 
influx. As intracellular calcium stores are depleted, mobilization of calcium from these 
stores activates arachidonate release. Evidence suggests that arachidonate liberated 
during calcium store depletion may participate in the store controlled opening of 
capacitative calcium influx channels. Since the experiments presented in this chapter do 
not discriminate between released arachidonate and its metabolites, it is presently 
unclear whether a P450 arachidonate metabolite is involved in capacitative calcium 
entry. Further experiments aimed at clarification of this issue are presented in Chapter 5
Additionally, arachidonate release is also coupled to capacitative calcium influx. 
This phase of arachidonate release is potentiated by PMA. This biphasic coupling of 
arachidonate release to capacitance calcium influx may be related to calcium dependent 
translocation of cPLA2 to localized increases in intracellular free calcium.
The experiments presented thus far focus on stimulation of capacitative calcium 
influx and mobilization of arachidonate independent of receptor-mediated events. This 
approach simplifies the study of effector systems downstream receptor-ligand binding. 
However, in order to accurately define a model for cPLA2 activation, the events 
described in our model should also occur in response to actual receptor mediated 
events. Such a study is the focus of Chapter 6.
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CHAPTER 5
EXOGENOUS FREE ARACHIDONIC ACID STIMULATES INFLUX OF 
EXTRACELLULAR CALCIUM AND RELEASE OF ENDOGENOUS 
ARACHIDONATE IN DIFFERENTIATED U937 CELLS.
S.l Background
During stimulation of differentiated U937 cells with thapsigargin, an initial phase 
of CPLA2 activity was coupled to depletion of intracellular calcium stores, preceding the 
opening of capacitative calcium influx channels in the plasma membrane (Section 4.2.5). 
This data suggests that this initial cPLA2 activity may participate in the formation of a 
calcium influx factor (CIF). CIF may be a discrete molecule, such as the diffusible 
second messenger described by Randriamampita (89). Alternatively, CIF may represent 
the assembly of a molecular complex involving the activity of low molecular weight 
GTPases (86, 95). Whatever its nature, the CIF serves as a communication link 
between intracellular calcium stores and store operated calcium influx channels in the 
plasma membrane (SOC), thereby regulating influx of extracellular calcium.
Free fatty acids can non-specifically effect ion fluxes and membrane permeability 
several cell systems (14, 107-109). In contrast to these non-specific effects, specific 
effects of arachidonate on calcium influx have been identified in pancreatic islets (110),
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neural tissue (15), adrenal chromaffin cells (12), and thyroid cells (13). In differentiated 
U937 cells, inhibition of CPLA2 with PGBx blocks capacitative calcium influx (Section 
4.2.6), supporting a role for free arachidonate (or an arachidonate metabolite) in 
generation of a CIF.
Experiments with econazole and other imidazole antimycotics suggest that a 
metabolite of a cytochrome P450 system may be involved in the generation of a CIF 
(98, 111). The precise P450 system involved is presently unknown. Arachidonic acid 
can be metabolized by cytochromes of the P450-4A series, resulting in the formation of 
arachidonic acid epoxide derivatives. Therefore, a P450 metabolite of arachidonic acid 
could be critical to the formation of the CIF. Econazole blocked thapsigargin- 
stimulated elevations in [Ca2+]i in differentiated U937, yet potentiated release of 
arachidonate (4.2.6). If a cytochrome P450 metabolite of arachidonate were involved in 
generation of CIF, one might expect these results. Inhibition of cytochrome P450 
would block P450-mediated arachidonate metabolism and subsequent generation of a 
CIF. Influx of extracellular calcium would then be inhibited. However, arachidonate 
release coupled to depletion of intracellular calcium stores might remain unaffected.
The evidence implicating a P450 metabolite in generation of a CIF is based 
solely on the use of imidazole antimycotics (econazole, miconazole, and ketoconazole). 
Recent reports suggest that antimycotics such as econazole, may inhibit capacitative 
calcium influx by physical blockage of calcium channels, similar to SKF96365 (112). 
Both SKF96365 and econazole do have quite similar structures (n-substituted 
imidazole). Thus, although econazole is reported to act through inhibition of 
cytochrome P450, the precise mode of action of this drug in the capacitative pathway is
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presently unclear.
If arachidonate and/or a metabolite thereof participates in the generation of CIF, 
it follows that:
1.) Exogenous application of arachidonate (and/or a metabolite) should 
stimulate influx of extracellular calcium
2.) Exogenous application of arachidonate (and/or a metabolite) should activate 
arachidonate release, as CPLA2 activity is also coupled to influx of extracellular 
calcium (Chapter 4).
3.) Arachidonate and/or a metabolite, should be detected in response to 
thapsigargin-stimulation.
Experiments designed to investigate these parameters are presented in this chapter.
5.2 Results
5.2.1 Effects of free arachidonate on [Ca2+]|.
If arachidonate and/or a metabolite is involved in the formation of a CIF, then 
exogenous free arachidonate should provoke an elevation in [Ca2+]i. However this type 
of experiment poses several technical problems. Experiments utilizing U937 cells are 
generally performed in PBS containing 2.5 1.1M fatty acid free albumin, the presence of 
which serves two main functions. First, albumin coats the cell, and enhances viability in 
PBS. Second, since albumin has multiple binding sites for free fatty acids, it serves as a 
“trap” in assays for arachidonate mobilization, by minimizing re-incorporation of 
[3H]arachidonate released in response to agonist stimulation. When exogenous 
arachidonate is given to cells suspended in PBS/glucose/albumin, a portion of the free
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fatty acid is immediately bound to albumin, and is therefore less readily available to the 
cell. To eliminate these difficulties, initial experiments on [Ca2+]i elevations were 
performed on cells resuspended in albumin-free PBS/glucose immediately prior to assay.
Arachidonate (100 pM) had no effect on [Ca2+]i in undifferentiated cells (data 
not shown). However 100 pM arachidonate elevated [Ca2+]i in differentiated cells 4 
fold over basal levels (from 38 to 173 nM, Figure 23). The response to exogenous 
arachidonate was composed of an initial rapid elevation in [Ca2+]j (first 5 seconds of 
response in figure 23) followed by a sustained phase, and was dose-dependent over the 
range 10-100 pM (data not shown). Linoleate (100 pM) also induced an elevation in 
[Ca2+]i, from a basal level of 38, to approximately 79 nM (Figure 23). However, the 
response to linoleate was much weaker, and lacked the initial phase of rapid elevation 
seen with arachidonate. Oleate (100 pM) was without effect. Viability after all 
incubations with free fatty acids was > 98%.
In the presence of albumin, the response to 100 pM arachidonate in 
differentiated cells was reduced by approximately 40-50% (Figure 24). Additionally, 
the dose-response for arachidonate was dramatically blunted (Figure 25). Arachidonate 
(50 pM) produced only a weak elevation in [Ca2+]i, (0.5 fold over basal levels), while 25 
pM arachidonate was without effect. These results are not surprising, considering that 
albumin reduces the effective concentration of arachidonate available to the cell. Thus, 
concentrations of > 100 pM may be the minimal concentration of arachidonate required 
to saturate albumin binding sites and allow availability of free fatty acid for stimulation. 
To promote viability and maintain consistency with arachidonate mobilization assays, all
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FIGURE 23
EFFECTS OF EXOGENOUS FATTY ACIDS ON [Ca2+], IN DIFFERENTIATED
U937 CELLS
Differentiated U937 cells were loaded with Fura-2 as described in Methods 2.9. 
Following loading, cells were washed twice in albumin-free PBS and resuspended in the 
same buffer. Cells were stimulated with 2.5-5 pi aliquots of the indicated fatty acid and 
[Ca2+]i was measured as described in Section 2.9. Results shown are representative of 
3-4 similar experiments performed on different days.










Reproduced with permission of the copyright owner. Further reproduction prohibited without permission
FIGURE 24
THE EFFECTS OF ALBUMIN OF EXOGENOUS ARACHIDONATE- 
STIMULATED INCREASES IN [Ca2+],.
Differentiated U937 cells were loaded with Fura-2 as described in Figure 23. After 
loading, cells were washed and resuspended in PBS with or without albumin (2.5 (iM), 
as described in Section 5.2.1. Arachidonate (100 pM) was added as indicated by the 
arrow. Results shown are representative of 3 separate experiments.
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FIGURE 25
EFFECTS OF EXOGENOUS ARACHIDONATE ON [Ca2+],: DOSE
RESPONSE.
Differentiated cells were loaded with Fura-2 and prepared as described in Methods 2.9. 
Exogenous arachidonate stimulated elevations in [Ca2+]i were determined in albumin 
containing medium as described in Figure 24. Results are representative of 3-4 separate 
experiments.
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further experiments were performed in albumin (2.5 pM) containing medium, using a 
fatty acid concentration of 100 pM. We reasoned that under these conditions, sufficient 
free fatty acid would be present, unbound to albumin, to allow adequate stimulation of 
cells.
To determine the requirements for extracellular calcium, differentiated cells were 
suspended in albumin containing medium. EGTA (1.1 mM, 2.5 pi) was added to cells 
in the spectrofluorometer cuvette, followed by 100 pM arachidonate (2.5 pi). Chelation 
of extracellular calcium with EGTA essentially abolished the effects of 100 pM 
arachidonate (Fig. 26). This indicates that the elevations of [Ca2+]i observed in response 
to stimulation with exogenous arachidonate are due to influx of extracellular calcium.
Pre-treatment of differentiated U937 with NDGA, an inhibitor of cytochrome 
P450-mediated arachidonate metabolism, had no effect on [Ca2+]i elevation stimulated 
by 100 pM arachidonate (Fig 26B). As NDGA inhibits cytochrome P450-medaited 
arachidonate metabolism, these results suggest that metabolism of arachidonate by this 
pathway is not required for stimulation of influx of extracellular calcium by exogenous 
arachidonate.
Pre-treatment of differentiated cells with PMA enhanced thapsigargin-stimulated 
influx of extracellular calcium (Chapter 4). It was therefore of interest to determine 
whether PMA pre-incubation could enhance the effects of exogenous arachidonate on 
elevations in [Ca2+];. Results shown in Figure 27 demonstrate that a 10 minute pre­
incubation of differentiated cells with 10 nM PMA potentiated exogenous arachidonate- 
stimulated elevations in [Ca2+]i by 2 fold.
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FIGURE 26
A. E FF E C T S O F  EX O G EN O U S A R A C H ID O N A TE O N  E L E V A T IO N S IN
[Ca2+]j A R E  D EPEN D EN T O N  EX TR A C ELL U LA R  C A L C IU M .
B. E FFE C T S O F  EX O G EN O U S A R A C H ID O N A TE O N  ELE V A T IO N S IN
[Ca2+]i A R E  N O T  A FFEC T ED  BY NDGA.
In Figure 26A, differentiated cells were stimulated with arachidonate in the presence of 
extracellular calcium, or in the presence of EGTA to chelate extracellular calcium, as 
described in the text. Measurement of [Ca2+]j was performed as described in Section 
2.9.
In Figure 26B, Fura-2 loaded differentiated cells treated with NDGA (40 pM) as 
indicated by the arrow. Approximately 2 minutes later, cells were stimuated with 100 
pM arachidonate. Results shown are representative of three similar experiments 
perfomed on different days.
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FIGURE 27
EFFECTS OF PMA PRE-INCUBATION ON ARACHIDONATE-STIMULATED
ELEVATIONS IN [Ca2+]i.
Differentiated cells were loaded with Fura-2, washed, and pre-incubated with or without 
PMA (10 nM) as described in Methods. Cells were stimulated with arachidonate as 
described in Figure 25. Results represent the maximum [Ca2+]i level attained in 
response to the indicated treatment. Basal levels represent [Ca2+]i in unstimulated cells. 
“PMA” indicates basal [Ca2+]i levels after a ten minute PMA pre-incubation.
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5.2.2 Effects of exogenous arachidonate on mobilization of endogenous 
arachidonate.
The findings obtained thus far suggest that exogenous arachidonate is capable of 
activating calcium influx in differentiated U937 cells. Results presented in Chapter 4 
indicated that cPLA2 activity (and hence release of endogenous arachidonate), occurred 
in response to elevations in [Ca2+]i due to both intracellular calcium store depletion, as 
well as influx of extracellular calcium through SOC. If exogenous arachidonate 
activates influx of extracellular calcium through SOC, then it should also activate cPLA2 
and induce release of endogenous arachidonate.
Differentiated and undifferentiated U937 cells were challenged with exogenous 
arachidonate ( 25-100 |iM) and mobilization of endogenous radiolabeled arachidonate 
was measured as described in Section 2.4. Undifferentiated cells did not release 
endogenous arachidonate when stimulated with exogenous arachidonate concentrations 
of up to 200 pM (data not shown). However, Figure 28 indicates that in differentiated 
cells, exogenous arachidonate activated mobilization of endogenous arachidonate in a 
dose dependent manner.
Fatty acid stimulation of endogenous arachidonate release was relatively specific 
for exogenous arachidonate. As indicated in Figure 29, neither linoleate nor oleate were 
as effective as exogenous arachidonate. Furthermore, PMA pretreatment potentiated 
the effects exogenous arachidonate on the release of endogenous arachidonate by 50- 
60% (Figure 29, filled bars). PMA pre-incubation had no significant effect on linoleate 
of oleate stimulated release of endogenous arachidonate.
88
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FIGURE 28
EXOGENOUS ARACHIDONATE STIMULATES MOBILIZATION OF 
ENDOGENOUS ARACHIDONATE.
Differentiated cells were prepared and radiolabeled as described in Methods 2.2-2.3. 
Arachidonate mobilization in response to stimulation with exogenous arachidonate was 
as described in Methods 2.4. Results represent the mean ± SE of 3-4 separate 
experiments performed in duplicate.
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FIGURE 29
EFFECTS OF EXOGENOUS FATTY ACIDS ON MOBILIZATION OF 
ENDOGENOUS ARACHIDONATE ARE SPECIFIC FOR ARACHIDONATE.
Radiolabeled differentiated cells were pre-incubated with or without PMA as described 
in Section 2.4. Cells were stimulated with the indicated concentrations of arachidonate, 
oleate, or linoleate as described in Figure 28. Results are normalized to percent increase 
over basal (unstimulated) arachidonate release, and represent the mean ±  SE of 3 
separate experiments performed in duplicate.
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5.2.3 Production of arachidonate metabolites by differentiated U937 cells in 
response to thapsigargin stimulation.
Results thus far suggest that exogenous free arachidonate stimulates both 
elevation in [Ca2+]i (via influx of extracellular calcium) and release of endogenous 
arachidonate in differentiated U937 cells. However, it is not clear whether arachidonate 
itself, or a metabolite of arachidonate, is directly responsible for these observations. 
Therefore, the products of thapsigargin-stimulated arachidonate release were examined.
For these experiments, differentiated U937 cells were stimulated with 1 |iM 
thapsigargin (± PMA), as described (Section 2.7). The entire incubation volume was 
acidified and extracted twice with ethyl acetate (Section 2.7). Extracts were 
chromatographed in ethyl acetate/iso-octane/acetic acid/water (110:50:20:10) (Section 
2.7). Thin layer chromatography results indicated that very little arachidonate 
metabolites were generated during stimulation with thapsigargin or PMA + 
thapsigargin. Released radiolabel was primarily in the form of free arachidonate (data 
not shown).
However, the low sensitivity of thin layer chromatography, combined with the 
extremely labile nature of many arachidonate metabolites, prompted further examination 
of extracts from thapsigargin-stimulated cells by HPLC. Thus, the same experiments 
were repeated, and examined via HPLC as described in Section 2.8. As our HPLC 
system is not presently capable of a positive identification of either prostaglandins or 
P450 arachidonate metabolites by mass, the column effluent was collected in 1 ml 
fractions. The presence of [3H]arachidonate metabolites in the fractions was determined 
by liquid scintillation. Compounds were tentatively identified by their reported retention
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times (72). Lipoxygenase products were measured by increases in absorbance at 270 
nm (237 nM for 5-HETE) during each HPLC run.
The results shown in Figure 30A indicate that [3H] labeled arachidonate 
metabolites corresponding to retention times reported for prostaglandins, P450 
products, and free arachidonate were produced in response to thapsigargin stimulation. 
Approximately 61% of the radiolabel was detected as free arachidonate, with 35% and 
4% present as prostaglandin and P450 metabolites, respectively. UV absorbance 
measurements made directly on column effluents confirmed that no lipoxygenase 
products were produced in differentiated U937 cells (data not shown), consistent with 
reports that indicate that these cells contain no 5-lipoxygaenase (77). Similar products 
were obtained in differentiated U937 cells pre-incubated with PMA, however the 
relative percentage of free arachidonate was increased to 70% (27 % prostaglandins and 
3 % P450 products; Figure 30B). Thus, free fatty acid is the primary arachidonate 
product generated in thapsigargin-stimulated differentiated U937 cells.
To examine the presence of cytochrome P450 arachidonate metabolites, 
additional incubations were done in the presence of 10 pM indomethacin (with or 
without thapsigargin ±  PMA). Indomethacin inhibits the cyclooxygenase pathway of 
the arachidonate cascade, thereby inhibiting production of prostaglandin metabolites 
(11). Thus, arachidonate metabolites formed in response to thapsigargin or PMA + 
thapsigargin, which were inhibited by incubation with indomethacin, would be 
cyclooxygenase products. Likewise, any products formed that were not inhibited by 
indomethacin would be cytochrome P450 metabolites, as lipoxygenase products are not 
produced by these cells.
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FIGURE 30
ARACHIDONATE METABOLITES PRODUCED IN RESPONSE TO 
THAPSIGARGIN OR PMA + THAPSIGARGIN STIMULATION IN 
DIFFERENTIATED U937 CELLS.
Differentiated cells were prepared and radiolabeled as described in Sections 2.2-2.3. 
Cells were pre-incubated with (Figure 30A) or without (Figure 30B) PMA (10 nM), 
followed by thapsigargin stimulation (Methods 2.8). Combined cells and supernatants 
from thapsigargin-stimulated incubations were extracted with ethyl acetate and analyzed 
by reverse phase HPLC in a methanol/water/ phosphoric acid gradient as described in 
Methods 2.8. Results are representative of 2 separate experiments performed in 
duplicate.
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Indomethacin inhibited production of [3H] arachidonate metabolites identified as 
prostaglandins (Fig. 31 A). Thapsigargin-stimulated elevations in [Ca2+]i and 
arachidonate release were unaffected by indomethacin treatment (data not shown). This 
precludes a role for prostaglandin metabolites in the capacitative pathway.
In differentiated cells treated with indomethacin, an increase in radiolabel 
associated with retention times of P450 arachidonate metabolites was detected (Figure 
31 A). However, if these P450 products were associated with elevation of [Ca2+]i, one 
would expect that indomethacin would increase thapsigargin-stimulated elevations in 
[Ca2+]i. Such an increase in [Ca2+]i was not detected in response to indomethacin.
Furthermore, in indomethacin-treated cells stimulated with PMA + thapsigargin, 
97% of the released radiolabel was in the form of free arachidonate. Indomethacin did 
not potentiate formation of cytochrome P450 metabolites (Figure 3 IB). Considering 
that PMA pre-treatment enhances both thapsigargin-stimulated elevations in [Ca2+]i and 
arachidonate release, it does not appear likely that a P450 arachidonate metabolite is 
involved in elevation of [Ca2+]j.
5.3 Discussion
The results presented in Chapter 4 suggested that arachidonate and/or its 
metabolites may be linked to the generation of a CIF, which functions as a 
communication link between empty intracellular calcium stores and SOC. The results 
presented in this Chapter suggest that free arachidonate itself may be a component of 
the CIF.
Consistent with this hypothesis, exogenous free arachidonate stimulated an 
elevation in [Ca2+]i in differentiated U937 cells. In the presence of albumin (2.5 |iM)
94
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FIGURE 31
EFFECTS ON INDOMETHACIN ON ARACHIDONATE METABOLITES 
PRODUCED IN RESPONSE TO THAPSIGARGIN OR PMA + 
THAPSIGARGIN STIMULATION IN DIFFERENTIATED U937 CELLS. 
Differentiated cells were stimulated as described in Figure 30. Indomethacin (10 |iM) 
was added during the pre-incubation period, as described in the text. HPLC was 
performed as described in Figure 30. Results are representative of 2 separate 
experiments performed in duplicate. The fractions in which prostaglandins, P450 
metabolites, and free arachidonate elute are indicated.
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arachidonate (100 pM) elevated [Ca2+]i 2-fold over basal levels. Similar results were 
observed in thyroid FRTL-5 cells (13). This increase is quite striking, considering that 
1.) a substantial portion of the exogenous arachidonate is bound to albumin and 
unavailable to the cell and 2.) exogenous treatment with arachidonate places a potential 
intracellular second messenger on the wrong side of the plasma membrane. As it is 
incorporated intracellularly, it is also subject to metabolic systems such as (3 oxidation 
and esterification, which would make the effective concentration of free arachidonate in 
the cell even lower. Neither linoleate nor oleate were as effective as arachidonate, 
suggesting that these observations are not due to non-specific effects of fatty acids on 
membrane permeability.
Undifferentiated cells did not respond to exogenous arachidonate with an 
elevation in [Ca2+]i. This suggests that free arachidonate is a specific stimulus for 
elevation of [Ca2+]j only in those cells with a fully developed capacitative calcium influx 
pathway. As results in chapter 4 demonstrate that undifferentiated U937 cells do not 
appear to have such a pathway, it follows that undifferentiated cells do not respond to 
exogenous arachidonate with an elevation in [Ca2+]i.
Exogenous arachidonate-stimulated elevations in [Ca2+Jj were dependent on 
extracellular calcium. In the presence of EGTA, exogenous arachidonate had no effect 
on [Ca2+]i. Thus, exogenous arachidonate appears to elevate [Ca2+]i downstream of 
intracellular store depletion, at the level of the calcium influx channel.
Pre-incubation of differentiated U937 cells with PMA potentiated the effects of 
exogenous arachidonate on elevations in [Ca2+]i. Results presented in Chapter 4 
demonstrated that PMA pretreatment potentiated influx of capacitative calcium, but did
96
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not affect intracellular calcium stores. This suggests that PMA enhances capacitative 
calcium influx downstream of intracellular store depletion and generation of the CIF, at 
the level of the SOC channel. If arachidonate does, in fact, activate the SOC channel, 
then its effects should be potentiated by PMA. In support of this hypothesis, PMA pre­
incubation potentiated elevations in [Ca2+]i stimulated by exogenous arachidonate. As 
PMA activates PKC (50) this could be mediated by effects of PKC on SOC channels. 
Alternatively, PKC could phosphorylate other components of the CIF, which enhance 
association with free arachidonate and further activation of influx of extracellular 
calcium.
Thapsigargin-stimulated cPLA2 activity was initially coupled to depletion 
intracellular calcium stores. A second phase of arachidonate mobilization was coupled 
to influx of extracellular calcium (Chapter 4). In these experiments, exogenous 
arachidonate stimulated influx of extracellular calcium, possibly through SOC. 
Consistent with the second phase of thapsigargin stimulated cPLA2 activity, exogenous 
arachidonate also stimulated release of endogenous arachidonate. Thus, consistent with 
the model for cPLA2 regulation presented in Chapter 4, exogenous arachidonate 
activated influx of extracellular calcium, which in turn stimulated cPLA2 activity at the 
level of the calcium influx channel. Furthermore, PMA potentiated exogenous 
arachidonate-stimulated release of endogenous arachidonate. In Chapter 4, it was 
demonstrated that PMA potentiation of cPLA2 activity occurred during influx of 
extracellular calcium, and did not affect that cPLA2 activity coupled to depletion of 
intracellular calcium stores. Consistent with these observations, PMA potentiation of 
arachidonate-stimulated release of endogenous arachidonate, also occurs during calcium
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influx, downstream of store depletion.
Examination of arachidonate and arachidonate metabolites generated in response 
to thapsigargin stimulation of differentiated U937 cells indicated that free arachidonic 
acid itself was the primary product. Although prostaglandin synthesis was evident, 
inhibition of the cyclooxygenase pathway with indomethacin had no effect on 
thapsigargin-stimulated elevations in [Ca2+]i or arachidonate release. Thus, 
prostaglandin metabolites do not appear to be involved in the capacitative pathway.
Previous experiments with the cytochrome P450 inhibitor, econazole, suggested 
that a P450 arachidonate metabolite may by involved in generation of the CIF. The 
amounts of P450 arachidonate metabolites produced during thapsigargin stimulation of 
differentiated U937 were very low (3-4% of the total radiolabled products) relative to 
free arachidonate (61-75% ). Additionally, pretreatment of differentiated U937 cells 
with an inhibitor of the P450 system of arachidonate metabolism, NDGA, did not block 
the effects of exogenous arachidonate. Thus, it does not appear likely that a P450 
arachidonate metabolite is involved in the generation of CIF. However, it is possible 
that some P450 metabolites were not separated from free arachidonate in our HPLC 
system. Thus, although primary products appear to be free arachidonate, GC/mass 
spectrometry would be required for positive confirmation.
Taken together, these results strongly suggests that free arachidonate may be a 
functional component of an intracellular effector system which serves as a link in the 
communication between intracellular calcium stores and SOC in the plasma membrane. 
This may occur through a direct action of arachidonate on the membrane environment 
surrounding calcium channels. Arachidonic acid and its metabolites have been
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demonstrated to modify ion channel gating in a variety of cell types (113). 
Alternatively, arachidonic acid may be a necessary component for the assembly of an 
effector complex, which in turn regulates the opening of capacitative calcium influx 
channels. It has been suggested that the signaling link between intracellular calcium 
stores and plasma membrane calcium channel involves a 
phosphorylation/dephosphorylation reaction (89, 94, 114); possibly regulated by a low 
molecular weight GTPase (86, 95). Free arachidonate has been shown to modulate the 
activity of GAP (115) and the translocation of rac p21s to the plasma membrane (105). 
Thus, an association between arachidonate and a low molecular weight GTPase or 
GTPase activating protein, may participate in regulation of capacitative calcium influx. 
Fasolato (95) suggests that the GTPase sensitive step in capacitative calcium influx may 
involve transport of vesicles containing calcium channels to the plasma membrane. In a 
cell free system, membrane fusion was modulated by both GTP and polyunsaturated 
fatty acids, of which linoleic and arachidonic were most effective (116).
In summary, depletion of intracellular calcium stores and activation of 
capacitative calcium influx in differentiated U937 cells results in release of significantly 
higher amounts of free arachidonate than other eicosanoid metabolites. Furthermore, 
results presented in this chapter suggest that free arachidonate may function as an 
intracellular second messenger that regulates [Ca2+]i levels by activation of capacitative 
calcium influx. This suggests a heretofore unknown role for cPLA^ apart from its well 
known role in initiation of the arachidonate cascade. In addition to being regulated by 
low levels of calcium itself, CPLA2 may participate in the regulation [Ca2+]i of 
cytoplasmic compartment. Initially, CPLA2 would be activated by a local increase in
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[Ca2+]j at the membrane of intracellular calcium stores in response to agonist-stimulated 
store depletion. Release of free arachidonate would then activate further increases in 
[Ca2+]i, through formation of a CIF. Thus, CPLA2 may be have a functional role in 
regulating intracellular free calcium levels, by mediating release of free arachidonate in 
response to agonist stimulation.
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CHAPTER 6
ARACHIDONATE MOBILIZATION IS COUPLED TO THE 
CAPACITATIVE CALCIUM INFLUX PATHWAY IN RECEPTOR-
MEDIATED EVENTS
6.1 Background
The basic concepts for cPLA2 regulation presented in Figure 22 were derived 
using thapsigargin as a direct stimulus for intracellular calcium store depletion. In 
actual receptor mediated events, G-protein or tyrosine kinase linked effector systems 
activate PLC, followed by generation of the second messenger IP3 (87, 93). IP3 binds 
to a receptor on intracellular calcium stores, stimulating a rapid efflux of calcium (85, 
8 6 , 8 8 ). In contrast, thapsigargin inhibits the Ca2+-ATPase of intracellular stores (99). 
Stores are depleted by a slow leakage of calcium, rather than the rapid release of store 
calcium seen in IP3 mediated events. Both mechanisms produce similar effects; 
depletion of store calcium followed by activation of capacitative influx.
If the model presented for regulation of cPLA2 in differentiated U937 is 
applicable to physiological signal transduction, then the basic components of this
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model should occur during actual receptor mediated stimulation. These include the 
following parameters:
1. Agonists which activate the IP3 pathway through receptor mediated
events should also activate CPLA2 .
2. Receptor mediated events that do not elevate [Ca2+]i via the
capacitative pathway should not activate arachidonate release.
3. Mobilization of arachidonate should be initiated in response to
depletion of intracellular calcium stores.
4. Mobilization of arachidonate should also accompany capacitative
calcium influx.
5. The time course of agonist-stimulated arachidonate release should 
correlate with the time course of agonist-stimulated elevations in 
[Ca2+]i.
6 . Inhibition of CPLA2 activity should inhibit agonist-stimulated 
capacitative calcium influx.
7. Arachidonate mobilization observed during receptor mediated 
events should be consistent with activation of CPLA2 .
The experiments presented in this Chapter are designed to address these issues.
Chemoattractants such as fMLP, stimulate both [Ca2+]i elevation and release of 
arachidonate in neutrophils (49, 117) and monocytes (118, 119). In both these cell 
types, fMLP receptors are coupled to an IP3 dependent signal transduction 
mechanisms (120, 121). Thus, fMLP results in activation of the capacitative calcium 
influx pathway. In human neutrophils, calcium influx stimulated by fMLP had identical
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properties to that stimulated by thapsigargin (119). Consequently, fMLP was chosen 
as an agonist for investigation in this study.
The purinergic receptor agonist, ATP, stimulates elevation of [Ca2+]i in U937 
(100, 122), macrophages (96), neutrophils (111,118), and other cells (13,123). U937 
cells have been reported to contain 2  subtypes of purinergic receptors, P2U and P^ 
(118, 122). The P2Z purinergic receptor activates a ligand gated channel cation 
channel, permeable to N a+, K+, and Ca2+ (124). The channel is activated by ATP (but 
not UTP), and inhibited by Mg2+ (124). In the macrophage, activation of P2Z 
purinergic receptors generates a rapid, almost instantaneous, increase in [Ca2+]i, 
dependent on extracellular calcium only (96, 124). There is no sustained phase of 
calcium influx, as is seen in activation of the capacitative pathway. IP3 is not produced 
and intracellular stores are unaffected. Rather, receptor-ligand binding results in direct 
activation of a receptor operated channel (ROC).
In contrast, the P2U purinergic receptor functions via activation of PLC, 
generation of IP3, and activation of the capacitative calcium influx pathway. Both 
ATP and UTP activate this purinergic receptor subtype (123, 124). In the 
macrophage, P2U receptor activation results in an initial rapid elevation of [Ca2+]i due 
to emptying of intracellular stores, followed by a sustained phase of capacitative 
calcium influx (96). In the case of the P211 receptor, influx of divalent cation is 
relatively specific for calcium as opposed to sodium and potassium (123-125). As 
preliminary results indicated that differentiated U937 respond to ATP with an 
elevation of [Ca2+]i, ATP was also chosen as an agonist for further study in 
differentiated U 937 cells.
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6.2 Results
6.2.1 Effects of the chemotactic peptide, fMLP, on elevation of [Ca2+]i in 
differentiated and undifferentiated TJ937 cells.
fMLP (10 pM) had no effect on [Ca2+]i in undifferentiated cells (results not 
shown). This is not surprising, as reports indicate that undifferentiated U937 cells do 
not have receptors for chemotactic peptides (68, 122). fMLP receptors 
characteristically develop in U937 cells upon monocytic differentiation (68).
In differentiated cells, fMLP produced a dramatic elevation in [Ca2+]i (Figure 
32). fMLP induced an initial rapid increase in [Ca2+]j, followed by a  sustained phase 
during which maximal levels of [Ca2+]i were attained. Stimulation of differentiated 
cells in calcium free medium abolished the sustained phase of [Ca2+]i elevation (Figure. 
32, lower trace). Similar results were observed when extracellular calcium was 
chelated with EGTA prior to fMLP stimulation (Figure 33). However, even in the 
absence of extracellular calcium, fMLP elevated [Ca2+]i approximately 3 fold over 
basal levels. These results are consistent with activation of the capacitative pathway 
and mobilization of calcium from intracellular stores.
To further dissect fMLP stimulated elevations in [Ca2+]i with respect to influx 
of extracellular calcium, differentiated U937 cells were treated with various inhibitors 
of calcium influx, as described in Chapter 4. Econazole (2 pM), an inhibitor of 
cytochrome P450, blocked 40-50% of the fMLP-stimulated elevation in [Ca2+]i, 
(Figure 33) similar to the effects observed in thapsigargin-stimulated cells. Ni2+, which 
physically blocks calcium channels, also reduced fMLP-stimulated increases in [Ca2+]i
104
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FIGURE 32
EFFECTS OF fMLP ON [Ca2+]i IN DIFFERENTIATED U937 CELLS.
Differentiated U937 cells were loaded with Fura-2 and stimulated with 10 |iM fMLP as 
described in Methods 2.9. The results shown are representative of 5-6 similar 
experiments performed on separate days.
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FIGURE 33
EFFECTS OF INHIBITORS OF CAPACITATTVE CALCIUM INFLUX ON 
fMLP-STTMULATED ELEVATIONS IN [Ca2+]it
Differentiated cells were loaded with Fura-2 as described in Methods 2.9. Inhibitors 
were added directly to cells in the spectrofluorometer cuvette, at the concentrations 
indicated in the Figure. fMLP was added after addition of inhibitors, as described in 
Figure 14. For calcium-free experiments, cells were prepared and stimulated as 
described in Figure 13. Results were normalized to the maximum [Ca2+]i level achieved 
by 10 pM fMLP (279.5 ± 50 nM) and represent the percentage of the 10 pM fMLP 
response. Data shown represents the mean + SE of 3-5 separate experiments.
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by 60% (Figure 33). SKF96365 (1 |jM), which specifically blocks capacitative 
calcium influx channels, inhibited 42%  of the fMLP-stimulated increase in [Ca2+]i 
response. Thus, consistent with effects observed in thapsigargin-stimulated 
differentiated cells, inhibitors of capacitative calcium influx inhibited that portion of the 
fMLP induced [Ca2+]j elevations associated with influx of extracellular calcium.
Inhibition of CPLA2 with PGBx also inhibited fMLP-stimulated increases in 
[Ca2+]i. Treatment of differentiated cells with PGBx resulted in an [Ca2+]i elevation 
equivalent to that obtained when differentiated cells were stimulated with fMLP in the 
absence of extracellular calcium (i.e. when [Ca2+]i elevations were produced solely by 
store depletion). Thus, inhibition of CPLA2 effectively blocked capacitative calcium 
influx in fMLP-stimulated cells. This supports the hypothesis that CPLA2  activity may 
be coupled to generation of a CEF. NDGA also inhibited fMLP-stimulated increases in 
[Ca2+]i but only by approximately 40-45%. Thus a portion of capacitative calcium 
influx was inhibited, but not as effectively as with PGBx.
6.2.2 Effects of fMLP on arachidonate mobilization in differentiated and 
undifferentiated U937.
For these experiments, arachidonate mobilization was assayed as described in 
Section 2.4 using 10 pM fMLP as a stimulus. In initial experiments, agonist- 
stimulated incubations for arachidonate mobilization were conducted for 5-10 minutes. 
Under these conditions, the observed levels of fMLP-stimulated arachidonate release 
were weak (only 1-3% above unstimulated levels), and in some cases undetectable. 
Experiments in Chapter 4 indicate that arachidonate mobilization is maximal at or
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slightly before the maximal level of [Ca2+]i attained in response to stimulation. In the 
case of fMLP, this was 2 minutes. When incubations were conducted for this shorter 
time period, significant arachidonate release was observed (8-11% of total 
incorporated radiolabel). Incubation for longer time periods resulted in re­
incorporation of released arachidonate, as evidenced by the appearance of radiolabel in 
the triglyceride fraction of lipid extractions of stimulated cells. This re-incorporation 
resulted in underestimation of arachidonate mobilization. Thus, all subsequent agonist 
stimulations were terminated at the time of maximal [Ca2+]i
As can be seen in Figure 34, fMLP (10 pM) resulted in a 4 fold increase over 
basal (unstimulated) levels of arachidonate release. Incubation in calcium free medium 
resulted in inhibition of only 40-45% of fMLP-stimulated arachidonate mobilization. 
Thus, a significant portion of fMLP-stimulated arachidonate mobilization was coupled 
to influx of extracellular calcium. However, 55-60% of the fMLP response was 
sustained in the absence of extracellular calcium, by mobilization of calcium from 
intracellular stores alone.
To further define the effects of influx of extracellular calcium on fMLP- 
stimulated arachidonate mobilization, the effects of inhibitors of capacitative calcium 
influx were examined as in Section 4.2.5. Consistent with effects seen with 
thapsigargin stimulation, econazole (2 pM) enhanced fMLP-stimulated arachidonate 
mobilization by approximately 25%. Inhibition of capacitative calcium influx with Ni2+ 
and SKF96365 inhibited 45 and 50 % of the fMLP stimulated response, respectively. 
Therefore, significant arachidonate release is also coupled to fMLP-stimulated influx 
of extracellular calcium.
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FIGURE 34
EFFECT OF INHIBITION OF CAPACITATIVE CALCIUM INFLUX ON 
1MLP-STIMULATED ARACHIDONATE MOBILIZATION IN 
DIFFERENTIATED U937 CELLS.
fMLP-stimulated arachidonate mobilization was determined in the presence of the 
inhibitors indicated, as described Figure 18. For calcium-free experiments, and 
experiments involving extracellular strontium, cells were prepared and stimulated as 
described in Figure 17. The concentrations of inhibitors were as follows : EGTA-1.1 
mM; Econazole-2 pM; Ni2+-5 mM; SKF96365-1 pM; PGBx-50 pg/ml; NDGA-40 pM; 
and S r^-l.l mM. Results were normalized to the release of radiolabel observed in 
response to 10 pM fMLP (9.09 ± 1.21% of total incorporated cellular radiolabel) and 
represent the percentage of the 10 pM fMLP response. Data shown represents the 
mean ±  SE of 3 separate experiments.
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fMLP-stimulated arachidonate mobilization was supported in the presence of 
extracellular strontium, at levels that were approximately 2-fold higher than that 
observed in the presence of extracellular calcium (Figure 34). cPLA2 can utilize 
strontium for translocation to membrane substrates, whereas whereas sPLA2 has an 
absolute requirement for calcium at the catalytic site. Thus, these results suggest that 
cPLA2 activity is coupled to the intracellular signal transduction mechanism observed 
in these experiments. Furthermore, PGBx and NDGA both inhibited fMLP stimulated 
arachidonate release (Figure 34) and elevations in [Ca2+]; (Figure 33). Therefore, 
cPLA2 activity appears to be coupled to fMLP-stimulated [Ca2+]i elevations and 
arachidonate mobilization.
6.2.3 Time course of fMLP-stimulated [Ca2+]i elevations and arachidonate 
release.
If cPLA2 activity is coupled to generation of a CEF, then the temporal release 
of arachidonate during fMLP stimulation should follow a similar course as the 
temporal increases in [Ca2+]j. Figure 35 demonstrates that this does occur. 
Arachidonate release was initiated within the first 10 seconds of fMLP stimulation, 
corresponding to the time during which calcium is mobilized from intracellular stores. 
Both [Ca2+]i and arachidonate release increased until the maximal levels of [Ca2+]i were 
attained, at about 90-120 seconds. After this period, calcium levels, as well as free 
arachidonate levels, decline in parallel (from approximately 3 to 5 minutes post 
stimulation, results not shown). An initial elevation in radiolabel also appeared in the 
diglyceride fraction within the first 30 seconds of agonist stimulation (< 1% o f total
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FIGURE 35
TIME COURSE OF fMLP-STIMULATED ARACHIDONATE 
MOBILIZATION AND ELEVATION IN [Ca2+]i.
The time course of fMLP-stimulated [Ca2+]i elevation and arachidonate mobilization 
were measured as described in Figure 19. Results represent mean ± SE of 3-4 separate 
experiments performed in duplicate.
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incorporated radiolabel), consistent with receptor mediated activation of PLC. 
However this elevated level of radiolabeled diglyceride remained constant throughout 
the first two minutes of stimulation.
Further evidence for the coupling of CPLA2 activity to [Ca2+]i elevation is 
presented in Figure 36. In this figure, arachidonate release is plotted as a function of 
[Ca2+]i. Once again, there is a striking correlation between released arachidonate and 
[Ca2+]i elevations stimulated by fMLP (correlation coefficient for the regression line in 
Figure 36 is 0.70).
6.2.4 Effects of A T P on elevation of [Ca2+]i in both differentiated and 
undifferentiated U937 cells.
For these experiments, differentiated or undifferentiated cells were loaded with 
Fura-2 and stimulated with 100 |iM ATP. This concentration of ATP has been 
routinely used in several cell lines to activate calcium influx (13, 96, 122, 126). Figure 
37 demonstrates that ATP induced an almost instantaneous elevation in [Ca2+]i in 
undifferentiated U937 (first 1-2 seconds), followed by a sustained phase. Upon initial 
examination, this response appears to be characteristic of capacitative calcium influx 
(store depletion followed by influx of extracellular calcium). However, stimulation of 
undifferentiated U937 with 100 (iM ATP in calcium free medium abolished these 
effects (Fig. 37, lower trace). This indicates that in undifferentiated U937, ATP- 
stimulated elevations in [Ca2+]i are dependent on influx of extracellular calcium, and 
are independent of depletion of intracellular calcium stores. These results are 
characteristic of the P2Z purinergic receptor (124).
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FIGURE 36
fMLP-STEMULATED ARACHIDONATE MOBILIZATION AS A FUNCTION
OF [Ca2+]i.
Results for arachidonate mobilization obtained in Figure 35 are plotted as a function of 
[Ca2+]i.
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FIGURE 37
EFFECTS OF ATP ON [CaJ+]f IN UNDIFFERENTIATED U937 CELLS.
ATP-stimulated elevations in [Ca2+]i were measured in Fura-2 loaded undifferentiated 
U937 cells as described in Methods 2.9. Results shown are representative of 4 similar 
experiments performed on different days.
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ATP (100 |aM) also stimulated an elevation in [Ca2+]i in differentiated U937 
cells (Figure 38). However, in the case of differentiated cells, the initial elevation in 
[Ca2+]j was not as immediate as that observed in undifferentiated cells (compare [Ca2+]i 
elevations during the first 2-5 seconds in Figures 37 and 38). UTP produced similar 
effects (data not shown). Furthermore, in calcium-free medium, ATP stimulated a 3 
fold increase over basal levels of [Ca2+]i in differentiated cells (Figure 38, lower trace). 
Similar results were observed when extracellular calcium was chelated in the presence 
of EGTA (Figure 39B). As extracellular calcium was not present under these 
conditions, the ATP-stimulated elevations in [Ca2+]j observed would be due to 
mobilization of calcium from intracellular stores. Thus, differentiated U937 cells 
responded to ATP with a depletion of intracellular calcium stores, followed a sustained 
phase of calcium influx. These results suggest ATP-stimulated increases in [Ca2+]i in 
differentiated cells are coupled, at least in part, to the P2U purinergic receptor.
6.2.5 ATP stimulates elevations in [Ca2+h through dissimilar pathways in 
differentiated and undifferentiated U937.
In undifferentiated cells, ATP-stimulated increases in [Ca2+]i appear to be 
entirely due to influx of extracellular calcium (characteristic of the P2Z receptor). In 
contrast, ATP-stimulated increases in [Ca2+]i in differentiated cells appear to also be 
coupled to depletion of intracellular calcium stores and activation of capacitative 
calcium influx (characteristic of the P2U receptor). Further experiments were 
conducted to dissect the calcium influx component of [Ca2+]j elevation, as in Section 
4.2.3. Figures 39 A and B demonstrate that differentiated U937 attained higher
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FIGURE 38
EFFECTS OF ATP ON [CaJ+]i IN DIFFERENTIATED U937 CELLS.
ATP-stimulated elevations in [Ca2+]j were measured in Fura-2 loaded differentiated cells 
as described in Methods 2.9. Results shown are representative of 4 similar experiments 
performed on different days.
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FIGURE 39
E FF E C T S O F  IN H IB IT O R S O F  C A PA C ITA TIV E C A L C IU M  IN FLU X  O N  
A T P-STIM U LA TE D  ELEV A TIO N S IN  [Ca2+]i IN  D IFFE R E N T IA T E D  AND 
U N D IFFER EN TIA TED  U937 C E L L S.
Differentiated (Figure A) and undifferentiated (Figure B) cells were loaded with Fura-2 
as described in Methods 2.9. ATP-stimulated elevations in [Ca2+]i in the presence of 
inhibitors of calcium influx was measured as described for fMLP in Figure 33. Results 
were normalized to the maximum [Ca2+]i level achieved by 100 pM ATP (261 ±25 nM 
for undifferentiated cells; 356 ± 64 for differentiated cells) and represent the percentage 
of the 100 pM ATP response. Data shown represents the mean ± SE of 3 separate 
experiments.
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elevations in [Ca2+]i in response to 100 pM ATP than did undifferentiated cells (355 ± 
64 vs. 261 ± 25). This suggests that differentiation may induce development of the 
P2U receptor (and the capacitative pathway), in addition to the P2Z, thereby resulting in 
enhanced elevations of [Ca2+]j in differentiated cells.
Econazole (2 pM), the inhibitor of cytochrome P450, was a more effective 
inhibitor of calcium influx in differentiated as opposed to undifferentiated, U937 cells. 
As econazole inhibits a cytochrome P450 system believed to be integral to capacitative 
calcium influx, the weak inhibition observed in undifferentiated cells (only 25-30% as 
compared to 50-60% inhibition in differentiated cells) may indicate lack of a fully 
developed capacitative calcium influx pathway in undifferentiated U937 cells. 
Undifferentiated cells appear to elevate [Ca2+]i in response to ATP via the P2Z 
purinergic receptor, followed by subsequent activation of ROC for calcium influx. 
Presumably, this pathway does not involve cytochrome P450, thus econazole does not 
inhibit calcium influx. Ni2+ (5mM) was also a more effective inhibitor of ATP- 
stimulated [Ca2+]j elevation in differentiated cells (compare Figs 39 A & B). 
SKF96365 (1 pM), which blocks capacitative calcium influx channels, had no effect in 
undifferentiated U937, yet it effectively blocked 50% of the ATP-stimulated [Ca2+]i 
elevation in differentiated cells. Taken together, these observations strongly suggest 
that ATP-stimulated calcium influx occurs by dissimilar pathways in differentiated and 
undifferentiated U937. Undifferentiated U937 cells appear to respond to ATP by 
activation of the P2Z receptor and direct influx of extracellular calcium through ROC. 
Differentiated cells appear to respond to ATP, at least in part, through the P2u 
purinergic receptor which initiates capacitative pathway for calcium influx.
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PGBx (50 pg/ml), which inhibits CPLA2, had no effect on ATP elevations in 
[Ca2+]i in undifferentiated cells (Figure 39A). However, in differentiated cells, PGBx 
inhibited ATP-stimulated elevations in [Ca2+]i by 75% (Fig. 39B). Similar results were 
observed with NDGA (Figs 39 A & B). Thus, cPLA2 appears to regulate [Ca2+]i 
elevations only in response to agonists which elevate [Ca2+]j by the capacitative 
pathway.
Inhibition of [Ca2+]j elevations by SKF96365, NDGA, and PGBx in 
differentiated cells stimulated with ATP was not as effective as inhibition observed in 
differentiated cells stimulated with thapsigargin (Chapter 4). As differentiated U937 
cells possess both P2U and Ptz purinerginc receptors (122), it is conceivable that ATP 
activated both these receptor subtypes in differentiated cells. SKF96365, PGBx, and 
NDGA would inhibit only that calcium influx associated with SOC channels (i.e. the 
P2u receptor subtype). Calcium influx through ROC mediated by the P& would be 
unaffected. To identify potential receptor activity, differentiated cells were 
challenged with 1 pM thapsigargin for 150 seconds, sufficient time to induce 
intracellular store depletion. Cells were subsequently stimulated with 100 pM ATP. 
The results shown in Figure 40 demonstrate that even when intracellular stores were 
depleted by thapsigargin, ATP induced an immediate rise in [Ca2+]i. These results are 
consistent with activation of a receptor, which would produce an additional 
increase in intracellular calcium by direct influx of calcium through ROC. Thus, 
differentiated U937 cells respond to ATP by activation of both P2u and P ^ purinergic 
receptors.
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FIGURE 40
DIFFERENTIATED CELLS CONTAIN P2Z RECEPTORS FOR ATP
Differentiated U937 cells were loaded with Fura-2 as described in Methods 2.9. 
Thapsigargin (1 pM) was added to cells in the spectrofluorometer cuvette as indicated 
by the arrow. After intracellular stores were depleted, ATP (100 pM) was added, as 
indicated by the arrow. The tracing shownenter is representative of 3 separate 
experiments performed on different days.
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6.2.6 Effects of ATP on mobilization of arachidonate in differentiated and 
undifferentiated U937 cells.
In these experiments, differentiated and undifferentiated cells were challenged 
with ATP for 2 minutes, as described in Section 2.4. [Ca2+]j measurements indicated 
that this was sufficient time for maximal elevations in [Ca2+]i to be attained.
Undifferentiated cells did not respond to ATP stimulation with increased 
mobilization of arachidonate (data not shown). This is not surprising, as the ATP- 
stimulated elevations of [Ca2+]j were not consistent with activation of the capacitative 
pathway in undifferentiated U937 cells. In differentiated cells, 100 pM ATP 
stimulation resulted in low, but significant mobilization arachidonate, approximately 2 
fold over basal (unstimulated) levels (Figure 41). In calcium free medium, ATP- 
stimulated release of arachidonate was inhibited by 30-40%. Figure 38 demonstrated 
that in the absence of extracellular calcium, ATP stimulated a rise in [Ca2+]i, 
presumably from emptying of intracellular stores. The results presented in Figure 41 
suggest that elevations in [Ca2+]i stimulated by depletion of intracellular stores are 
capable of sustaining 60-70% of the ATP-stimulated arachidonate mobilization.
Studies with inhibitors of calcium influx, as described in Section 4.2.5, were 
conducted to further examine ATP-stimulated arachidonate release as a function of 
influx of extracellular calcium. Consistent with results observed with thapsigargin and 
fMLP, inhibition of cytochrome P450 by econazole (2pM) increased ATP-stimulated 
arachidonate release in differentiated U937 cells. Inhibitors which blocked 
capacitative calcium influx channels, Ni2+ and SKF96365, also blocked 30-40% of 
ATP-stimulated arachidonate mobilization. Thus, inhibition of capacitative calcium
121
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FIGURE 41
EFFECT OF INHIBITION OF CAPACITATIVE CALCIUM INFLUX ON ATP- 
STIMULATED ARACHIDONATE MOBILIZATION IN DIFFERENTIATED
U937 CELLS.
ATP-stimulated arachidonate mobilization was determined as described for fMLP in 
Figure 34. The concentrations of inhibitors were as follows : EGTA-1.1 mM; 
Econazole-2 pM; Ni2+-5 mM; SKF96365-1 pM; PGBx-50 pg/ml; NDGA-40 |jM; and 
Sr2+- l.l  mM. , Results were normalized to the release of radiolabel observed in 
response to 100 pM ATP (4.02 ± 0.8 % of total incorporated cellular radiolabel) and 
represent the percentage of the 100 pM ATP response. Data shown represents the 
mean + SE of 3 separate experiments performed in duplicate.
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influx blocks a portion of ATP-stimulated arachidonate mobilization (i.e., that portion 
which is coupled to capacitative calcium influx).
In conjunction with their inhibitory effects on increases in [Ca2+]i, both PGBx 
and NDGA also inhibited 51-55% of ATP-stimulated arachidonate mobilization. 
PGBx was most effective, as this compound reduced ATP-stimulated arachidonate 
mobilization to control (unstimulated) levels. These results are consistent with the 
hypothesis that CPLA2 plays a regulatory role in the capacitative calcium influx 
pathway.
6.2.7 Time course of ATP stimulated arachidonate release and elevation of 
[Ca2+],.
Consistent with both fMLP (6.2.3) and thapsigargin (Chapter 4) Figure 42 
demonstrates that ATP-stimulated release of arachidonate parallels ATP-stimulated 
elevation in [Ca2+]i for the first two minutes of agonist stimulation. Arachidonate 
release is increased approximately 2 fold above basal levels within the first 10 seconds 
of ATP stimulation, and parallels [Ca2+]j elevations until maximal [Ca2+]i levels are 
attained. Thus, arachidonate mobilization is initiated during intracellular store 
depletion, and continues during the sustained, or calcium influx phase of the ATP 
response. As [Ca2+]i decreases, levels of free arachidonate follow. This suggests a 
correlation between ATP-stimulated mobilization of arachidonate and [Ca2+]j levels in 
differentiated U937. Further evidence for a correlation between arachidonate 
mobilization and [Ca2*]i is presented in Figure 43. Here, arachidonate mobilization is 
represented as a function of [Ca2+]i. As can be seen from this graph, release of
123
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FIGURE 42
TIME COURSE OF ATP-STIMULATED ARACHIDONATE MOBILIZATION
AND ELEVATION IN [Ca2+],.
The time course of ATP-stimulated [Ca2+]j elevation and arachidonate mobilization were 
measured as described for fMLP in Figure 35. Results represent mean ± SE of 3-4 
separate experiments performed in duplicate.
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ATP-STIMULATED ARACHIDONATE MOBILIZATION AS A FUNCTION
OF [Ca2+]i.
Results for arachidonate mobilization obtained in Figure 42 are plotted as a function of 
[Ca2+]i.
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arachidonate correlates well with the levels of [Ca2+]j stimulated during the first 2 
minutes of ATP stimulation (correlation coefficient = 0.78). These results strongly 
suggest that mobilization of arachidonate may regulate capacitative calcium influx.
6.3 DISCUSSION
The results presented in this chapter support the model for cPLA2 activation 
presented in Chapter 4 (Figure 22) with physiological receptor mediated events. The 
following criteria have been met:
6.3.1. Agonists which activate the IP3 pathway through receptor mediated 
events should also activate PLA2.
This has been demonstrated in monocytes (97, 127, 128), and many other cell 
lines (13, 40, 43, 129, 130). Both ATP and fMLP elevate [Ca2+]i in monocytes and 
neutrophils via nymediated activation of capacitative calcium influx (96, 119). Our 
results confirm that both ATP and fMLP appear to function in this capacity in 
differentiated U937 cells. Stimulation of differentiated cells with ATP or fMLP 
resulted in a rapid elevation of [Ca2+]j that was independent of extracellular calcium, 
followed by a sustained phase of capacitative calcium influx. This response is 
characteristic of the capacitative pathway. Furthermore, both ATP and fMLP 
stimulated influx of extracellular calcium was inhibited by SKF96365, an inhibitor of 
the SOC of the capacitative pathway. Thus, ATP and fMLP appear to function via IP3 
mediated capacitative pathway activation. Consistent with our model, activation of 
this pathway by ATP and fMLP resulted in arachidonate mobilization in differentiated 
U937.
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2. Receptor mediated events that do not elevate [Ca2+]j via the capacitative 
pathway should not activate arachidonate release.
In both differentiated and undifferentiated U937 cells, the purinergic receptor 
agonist, ATP, induced elevations in [Ca2+]j. However, in undifferentiated cells, [Ca2+]i 
elevations appeared to be almost entirely dependent on influx of extracellular calcium. 
This suggests that in undifferentiated cells, the P2Z purinergic receptor subtype 
mediates the ATP response. P2Z purinergic receptors exert direct control over a 
ligand-gated channel (123, 124, 131). Upon activation, influx of cation occurs 
immediately, without effect on intracellular calcium stores. Further support for the 
presence of P2Z receptors in undifferentiated U937 cells is demonstrated with the use 
of SKF96365. This pharmacological agent specifically blocks store-operated calcium 
influx channels (SOC). However, in undifferentiated U937, SKF96365 had no effect 
on ATP-stimulated elevations in [Ca2+];, suggesting that calcium influx is not regulated 
via the capacitative pathway.
Although undifferentiated cells responded to ATP with increased levels of 
[Ca2+]i this increase in [Ca2+]i was not coupled to arachidonate release, even though 
these cells have high quantities of functional CPLA2 . Thus, receptor-mediated 
elevation of [Ca2+]j by mechanisms other than depletion of intracellular calcium stores, 
does not appear to activate arachidonate release. Similar results were presented in 
Chapter 4, section 4.2.4. Arachidonate mobilization did not appear to be coupled to 
direct A23187-mediated calcium transport across the plasma membrane. Rather, it 
appeared to only be coupled to A23187 mediated depletion of intracellular calcium 
stores.
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In differentiated U937 cells, which possess P2U receptors, the capacitative 
pathway was activated by ATP. Consistent with our model for cPLA2 regulation, 
arachidonate mobilization was also activated by ATP in differentiated cells. However, 
ATP-stimulated arachidonate release was weak, compared to that observed with 
fMLP. For example, 10 pM fMLP stimulates a maximal [Ca2+]i level of 280 nM, and 
release of 9.1% of incorporated radiolabeled arachidonate. ATP (lOOpM) stimulated 
[Ca2+]i elevations of 355 nM, yet maximal arachidonate mobilization was only 4%. 
Thus, two different agonists generated relatively similar levels of [Ca2+]i but not of 
arachidonate mobilization. However, elevation of [Ca2+]j in differentiated cells 
stimulated with ATP may occur through more than one pathway. Although results 
presented here and in Chapter 4 suggest that differentiated cells develop a capacitative 
calcium entry pathway as a consequence of differentiation, it is also possible that direct 
receptor operated cation channels such as the P2Z receptor may co-exist. 
Differentiated U937 cells (100) and macrophages (131) have been reported to contain 
both P2u and P2Z purinergic receptor subtypes. If [Ca2+]i elevation occurs by two 
separate mechanisms, such as P2u and P2Z receptors, only one (P2u) may activate the 
capacitative pathway. Thus, out of the total increase in [Ca2+]i, only a portion is due 
to the capacitative pathway. This would account for the decreased sensitivity of 
arachidonate release to [Ca2+]j elevations observed in differentiated cells stimulated 
with ATP, as only calcium originating from activation of the capacitative pathway 
activated arachidonate mobilization. Thus, the ATP-stimulated calcium response 
undifferentiated U937 may represent a composite of the activities of these two 
receptors, only one of which (the P2u) activates cPLA2.
128
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3. Mobilization of arachidonate should be initiated in response to depletion of 
intracellular calcium stores.
Stimulation of differentiated cells with ATP and fMLP under calcium free 
conditions produced an elevation in [Ca2+]i consistent with depletion of intracellular 
calcium stores. Arachidonate mobilization also occurred under calcium free 
conditions, indicating that depletion of calcium from stores alone could activate and 
sustain CPLA2 activity. In fact, 40-50% of the fMLP and ATP-stimulated 
arachidonate mobilization was maintained, even in the absence of extracellular 
calcium. Thus, in differentiated U937 cells stimulated with either ATP or fMLP, 
depletion of intracellular calcium stores was coupled to mobilization of arachidonate. 
This suggests that a significant portion of CPLA2 activity lies upstream of capacitative 
calcium influx, even in receptor mediated events.
The amount of arachidonate release coupled to agonist-stimulated capacitative 
calcium influx appeared to be slightly lower than that observed with thapsigargin (75- 
80%, Figure 18). However, one must recognize that thapsigargin stimulation of 
differentiated U937 resulted in [Ca2+]j elevations of 600-700 nM, most of which was 
due to influx of extracellular calcium. During agonist-stimulated signal transduction 
events, IP3 receptors on intracellular calcium stores are inhibited by [Ca2+]i elevations 
of approximately 300 nM (132, 133). Thus, at this level of [Ca2+]j, capacitative 
calcium influx is essentially “turned off’. During thapsigargin stimulation, intracellular 
calcium stores remain empty, independent of the IP3 receptor, and there is no feedback 
mechanism for maintaining [Ca2+]i below 300 nM. Thus, the amount of cPLA2 activity
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stimulated by influx calcium could be much higher during thapsigargin stimulation, as 
actual calcium influx itself is increased over that normally observed in signal 
transduction events.
4. Mobilization of arachidonate should also accompany capacitative calcium 
influx.
In differentiated cells, ATP and fMLP stimulated mobilization of arachidonate 
were potentiated under conditions which permit capacitative calcium influx (i.e. in the 
presence of extracellular calcium). Thus, agonist-stimulated influx of capacitance 
calcium was also coupled to arachidonate release. Arachidonate release coupled to 
influx of extracellular calcium was inhibited by Ni2+ (5mM), which physically blocks a 
wide range of calcium channels (88), and by SKF96365, which specifically block SOC 
(101).
In undifferentiated cells, ATP-stimulated influx of extracellular calcium was 
consistent with activation of the P2Z purinergic receptor subtype. Thus, calcium influx 
occurred directly through ROC.
5. The time course of agonist-stimulated arachidonate release should correlate 
with the time course of agonist-stimulated elevation in [Ca2+]i
The time course for both fMLP and ATP stimulated elevations in [Ca2+]i 
correlated with those of arachidonate release. In both cases, arachidonate mobilization 
was evident (2 fold over basal levels) within ten seconds of agonist stimulation. Thus, 
arachidonate release occurred as intracellular stores were undergoing depletion.
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Release of arachidonate continued until maximal levels of [Ca2+]i were attained. Taken
lr
together with results presented in Chapter 5 regarding the ability of arachidonate to 
activate influx of extracellular calcium, these results are consistent with a role for 
CPLA2 in the generation of a CIF. CPLA2 activity, initiated by localized increases in 
calcium due to depletion of intracellular calcium stores, could generate free 
arachidonate. Arachidonate in conjunction with a low molecular weight GTPase, may 
then regulate formation of a CIF which activates SOC calcium influx. Once cells have 
attained a maximal [Ca2+]i level, IP3 receptors on intracellular calcium stores are 
inhibited. Calcium no longer is available for CPLA2 activity, and the CIF is no longer 
generated
6. Inhibition of CPLA2 activity should inhibit agonist-stimulated capacitative 
calcium influx.
In differentiated U937 cells both ATP and fMLP stimulated arachidonate 
release were inhibited by the PLA2 inhibitor, PGBx. The ATP and fMLP-stimulated 
influx of extracellular calcium was also inhibited by PGBx. However, depletion of 
intracellular store calcium was not affected. These observations support a role for 
cPLA2 in initiation of capacitative calcium influx in response to intracellular calcium 
store depletion during receptor mediated events.
7. Arachidonate mobilization observed during receptor mediated events should 
be consistent with activation of cPLA2.
During both ATP and fMLP-stimulation, intracellular free calcium
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concentrations are in the sub-micromolar range. This precludes a role for SPLA2, as 
this enzyme requires millimolar calcium for catalysis. Furthermore, arachidonate 
mobilization in response to stimulation by either fMLP or ATP was sustained in the 
presence of extracellular strontium. As CPLA2 can utilize strontium for translocation 
and activation, these results further support a role for cPLA2
The results presented in this chapter are consistent with previous reports which 
demonstrate that cPLA2 is activated by receptor-mediated events that result in 
activation of PLC and subsequent production of EP3 (13, 126). However, rather than 
being a simple consequence of PLC activation, the present results suggest that 
activation of cPLA2 may be an integral component of an effector system which 
modulates capacitative calcium influx.
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CHAPTER 7 
CONCLUSIONS
The conclusions below summarize the results obtained in this study on in situ 
regulation of CPLA2 . A cellular system in which CPLA2  can be studied has been 
identified, and the activity of CPLA2 has been characterized in this system. Furthermore, 
it was found that the differentiation-induced activity of CPLA2  is coupled to 
differentiation-induced development of a functional capacitative calcium influx pathway. 
These experiments have identified the cellular components of calcium dynamics which 
control CPLA2 translocation and activation by the capacitative pathway. However, in 
addition to the role of calcium in regulation of CPLA2, CPLA2 itself may be integrally 
involved in the regulation of agonist-stimulated elevations in [Ca2+]i levels. Thus, in 
addition to its role in activation of the arachidonate cascade, this thesis identifies a 
potential novel role for CPLA2  as an effector system which modulates capacitance 
calcium influx.
7.1 DMSO-differentiation of U937 cells induces an enhanced capacity to
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mobilize arachidonate in response to a calcium signal.
Although undifferentiated U937 cells contain high quantities of cPLA2 which 
increase only modestly with differentiation, A23187 stimulated arachidonate 
mobilization in situ is low, and relatively non-specific for arachidonate. DMSO- 
differentiation of U937 cells results in significant enhancement of arachidonate 
mobilization.
7.2 The arachidonate mobilizing activity observed in differentiated U937 cells 
is consistent with the in vitro characteristics of cPLA2.
a.) cPLA2 can be distinguished by its sensitivity to low calcium and 
arachidonyl specificity.
cPLA2 has two distinguishing characteristics in vitro; sensitivity to sub­
micromolar elevations in calcium and a preference for arachidonyl containing 
phospholipid substrates (22). Consistent with in vitro observations, A23187-stimulated 
arachidonate mobilization in differentiated U937 was activated by nannomolar 
elevations in [Ca2+]j., and was specific for arachidonate, as compared to oleate. Thus, 
differentiated U937 appears to be a suitable model system in which to study in situ 
regulation of cPLA2 activity.
b.) Extracellular strontium can be utilized to differentiate sPLA2 
activity from cPLA2 activity in situ.
In the U937 cellular system, extracellular calcium can be replaced by 
extracellular strontium without due compromise of biological activity under the 
incubation conditions used in this study. sPLA2 has an absolute requirement for
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calcium, and is inhibited in the presence of strontium (39). In contrast to SPLA2, CPLA2  
can utilize strontium as a substitute for calcium. In the absence of extracellular calcium, 
(and presence of extracellular strontium) thapsigargin stimulation results in influx of 
extracellular strontium. Strontium also forms a complex with Fura-2, and intracellular 
concentrations of this divalent cation can be readily measured using the dissociation 
constant for the Sr^/Fura^ complex. Agonist-stimulated arachidonate release observed 
in the presence of strontium would be due to activation of cPLA2, as sPLAj is inhibited 
under these conditions. This represents a novel in situ mechanism in which the effects 
of cPLA2 and SPLA2 can be dissected from each other. In differentiated U937 cells, 
thapsigargin stimulated both influx of extracellular strontium, and arachidonate release. 
Thus, thapsigargin stimulation was coupled to CPLA2, rather than SPLA2 .
7.3 PMA pre-incubation potentiates A23187-stimulated arachidonate 
mobilization in differentiated U937 cells.
CPLA2 is phosphorylated in situ in response to PMA (33), zymosan (47), 
bacterial lipopolysaccharides (64), and other agents. Although the unphosphorylated 
enzyme is active and responds to calcium, evidence suggests that phosphorylation 
enhances the Vmax for catalytic activity. Pretreatment of differentiated U937 cells with 
10 nM PMA for 10 minutes prior to A23187 stimulation dramatically potentiated 
A23187-stimulated arachidonate mobilization. Thus, our results suggest that 
phosphorylation events may further potentiate in situ arachidonate mobilization in 
response to a calcium signal.
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7.4 Phosphorylation alone is insufficient stimulus for CPLA2 activation in 
differentiated U937 cells.
In differentiated and undifferentiated U937 cells, PMA alone was insufficient 
stimulus for arachidonate mobilization, unless combined with a calcium signal. These 
results suggest that regulation of CPLA2 by phosphorylation is secondary to activation 
of CPLA2 by an elevation in [Ca2+]j, which permits association of CPLA2 with membrane 
substrates.
7.5 A23187 and PMA + A23187-stimulated arachidonate mobilization 
increases during the temporal development of monocytic differentiation in U937 
cells.
During DMSO-induced differentiation, A23187 stimulatable arachidonate 
mobilizing activity developed during two distinct phases, early and late in the 
differentiation time course. Maximal levels of A23187-stimulated arachidonate 
mobilization occurred in conjunction with growth cessation and development of the 
macrophage phenotype. The ability of PMA to potentiate A23187-stimulated 
arachidonate mobilization occurred early in the differentiation time course (complete by 
36 hours) and remained at this level throughout the differentiation process.
As undifferentiated cells contain high levels of functional enzyme, these results 
suggest that differentiation induces CPLA2 regulatory elements, which are lacking or 
inactive in undifferentiated cells.
7.6 Differentiation of U937 cells alters intracellular calcium dynamics and
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enhances the capacitative calcium influx pathway.
Data presented in Chapters 4 and 6 indicate that U937 cells undergo significant 
alterations in intracellular calcium dynamics during the differentiation process. 
Differentiated U937 cells attained significantly higher levels of [Ca2+]i in response to 
A23187 and thapsigargin than did undifferentiated cells. This increased calcium 
responsiveness was due to development of the capacitative calcium influx pathway.
Dissection of the calcium response in differentiated and undifferentiated U937 
cells indicates that differentiation induces alterations in both components of capacitative 
calcium influx, intracellular calcium stores and store operated calcium influx channels 
(SOC). Differentiated cells had larger thapsigargin-stimulatable intracellular calcium 
stores than did undifferentiated cells, as evidenced by the higher elevations in [Ca2+]i 
attained in response to thapsigargin stimulation in calcium free medium. Additionally, 
the characteristics of calcium influx channels appeared to be altered with differentiation. 
Thapsigargin-stimulated calcium influx in undifferentiated cells was not inhibited by 
econazole or SKF96365, both of which are relatively specific for capacitative calcium 
influx channels. In contrast, calcium influx in differentiated cells was significantly 
inhibited by these compounds. This suggests that either a different calcium influx 
channel is present, or that an existing channel has been structurally modified.
7.7 The enhanced capacity to mobilize arachidonate in response to a calcium 
signal is coupled to differentiation induced alterations in the capacitative calcium 
influx pathway.
Undifferentiated U937 cells did not release arachidonate in response to
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thapsigargin stimulation. In contrast, differentiated cells responded to thapsigargin with 
a dose dependent mobilization of arachidonate. Thus, in differentiated cells, activation 
of the capacitative pathway was coupled to mobilization of arachidonate. In actual 
receptor mediated events, activation of the capacitative pathway is coupled to receptor- 
mediated activation of PLC, followed by generation of IP3 . Agonists which function 
through this signal transduction network, such as ATP and fMLP, also activated 
arachidonate mobilization in differentiated U937 cells.
7.8 Arachidonate mobilization is coupled to both phases of the capacitative 
pathway; depletion of intracellular calcium stores, and influx of capacitative 
calcium.
In differentiated U937 cells, significant thapsigargin-stimulated arachidonate 
release were observed even in the absence of extracellular calcium, indicating that 
elevations in [Ca2+]i resulting from depletion of intracellular calcium stores alone were 
capable of initiating and sustaining arachidonate mobilization. Arachidonate release 
coupled to intracellular store depletion was even more evident in receptor mediated 
events stimulated by fMLP or ATP. Stimulation of differentiated cells with ATP or 
fMLP in the absence of extracellular calcium resulted in a 2-4 fold increase in 
arachidonate mobilization over basal (unstimulated) levels. Thus, calcium originating 
from depletion of intracellular stores alone could both activate and sustain CPLA2  
activity.
Additionally, a portion of the total agonist-stimulated arachidonate release was 
coupled to influx of extracellular calcium. Inhibitors of capacitative calcium influx
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(econazole, SKF96365, Ni2+) effectively inhibited arachidonate mobilization coupled to 
this phase of the capacitative pathway. However, the results presented here suggest 
that only calcium influx arising from the SOC of the capacitative pathway result in 
arachidonate mobilization. ATP stimulated calcium influx through P2Z receptor 
operated channels did not result in mobilization of arachidonate.
This suggests that CPLA2 must somehow be specifically coupled to the 
capacitative pathway, as it does not respond to intracellular calcium elevations 
originating from other sources (i.e. receptor operated channels). This may involve 
potential binding proteins, which physically couple the enzyme to either SOC or 
intracellular calcium stores, possibly even the CIF itself. Alternatively, depletion of 
intracellular calcium stores could release some form of inhibitory constraint, thereby 
coupling CPLA2 activity to the capacitative pathway.
7.9 CPLA2 activity may be coupled to the generation of a calcium influx factor 
(CIF) which serves as a communication link between empty intracellular calcium 
stores and store operated calcium influx channels.
The time course of thapsigargin, ATP, and fMLP stimulated elevations in [Ca2+]j 
and arachidonate release in differentiated U937 cells indicates that CPLA2  activity is 
initiated during depletion of intracellular calcium stores, and continues until maximal 
levels of [Ca2+]i are attained. Furthermore, inhibition of cPLA2 with the PLA2 inhibitor, 
PGBx, inhibited agonist-stimulated elevations in [Ca2*]j, as well as arachidonate release. 
Results presented in Chapters 4 and 6 suggest that PGBx primarily inhibited capacitative 
calcium influx, with little effect on calcium store depletion. Thus, inhibition of CPLA2
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blocked capacitative influx, supporting a role for CPLA2 in the generation of a CIF. 
CPLA2 is activated upon intracellular store depletion, and inhibition of CPLA2 blocks 
capacitative influx.
Further support for this hypothesis comes from evidence presented in Chapter 5. 
The product of cPLA2 activity, arachidonic acid, was capable of activating calcium 
influx when exogenously applied to differentiated cells. This effect was relatively 
specific for arachidonate. Consistent with effects on capacitative calcium influx 
channels, exogenous arachidonate also activated release of endogenous arachidonate. 
Thus, arachidonate itself, or in conjunction with other components of a CEF, may 
regulate store operated calcium influx channels.
7.10 PMA potentiates influx of capacitative calcium, and arachidonate release 
coupled to influx of capacitative calcium.
PMA potentiated thapsigargin and A23187-stimulated elevation in [Ca2+]i. The 
effects of PMA were inhibited by staurosporine ( 1 pM). Results from thapsigargin 
time course experiments indicate that PMA potentiates [Ca2+]i via increasing 
capacitative calcium influx. As PMA activates PKC, this suggests that PKC may 
somehow be involved in regulation of store controlled calcium influx channels. In 
further support for a role for PKC in regulation of SOC, PMA pretreatment enhanced 
calcium influx stimulated by exogenous arachidonate.
7.11 PMA elevated basal levels of [Ca2+]i in both differentiated and 
undifferentiated U937 cells.
140
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Consistent with a role for PKC in regulation of [Ca2+],-, a 10 minute pre-incubation of 
differentiated or undifferentiated U937 cells essentially doubled the basal levels of 
intracellular free calcium. Preliminary experiments in calcium free medium indicated 
that this effect of PMA required the presence of extracellular calcium. This suggests 
that PMA may activate isoforms of PKC which regulate calcium channel activity. 
Alternatively, effects on the plasma membrane Ca2+-ATPase could also be involved. 
The increase in basal [Ca2+]i produced by PMA did not occur rapidly, but occurred quite 
gradually during the ten minute PMA incubation period. Arachidonate release was not 
activated by this increase in calcium, suggesting that the capacitative pathway may not 
be involved. This elevation in basal [Ca2+]; may be one of the mechanisms by which 
short term exposure to PMA “primes” cells for subsequent agonist stimulated effects.
7.12 PMA may have a dual role in potentiation of arachidonate release
PMA induces phosphorylation of CPLA2 in situ, producing increased enzymatic 
activity of the partially purified enzyme in vitro. However our results also indicate that 
the in situ effects of PMA on arachidonate mobilization may also be due to a direct 
effect of PKC on capacitative calcium influx. As PMA pretreatment enhances influx, 
more calcium is available for CPLA2 translocation and activation. Thus, PKC may have 
a dual role in regulation of arachidonate release. It may have effects on calcium influx, 
as well as on cPLA2 directly. Regardless of the specific mechanism involved, PMA 
potentiation occurred only during the phase of capacitative calcium influx, suggesting 
that PKC mediated events lie downstream of calcium store depletion and initial 
mobilization of arachidonate.
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7.13 A cytochrome P450 metabolite of arachidonate does not appear to be 
involved in generation of a CIF.
Experiments with the imidazole antimycotic, econazole, have suggested that 
generation of a CIF and influx of capacitative calcium is controlled, in part, by a 
cytochrome P450 dependent system (98). Furthermore, treatment of differentiated cells 
with NDGA, an inhibitor of the cytochrome P450 pathway of the arachidonate cascade, 
blocked both agonist and thapsigargin-stimulated elevations of [Ca2+]j. Thus, we 
reasoned that a likely candidate for a CIF would be a P450 metabolite of arachidonate. 
Although NDGA inhibited agonist-stimulated release of arachidonate and elevations in 
[Ca2+]j, NDGA had no effects on arachidonate release or [Ca2+]i elevation stimulated by 
exogenous arachidonate. If a P450 arachidonate product were involved in stimulation 
of capacitative calcium influx, one would expect that NDGA should block the effects of 
free arachidonate, as it could not be metabolized to the active P450 compound. This 
suggest that a P450 arachidonate metabolite is not involved in generation of CIF. 
HPLC analysis of thapsigargin stimulated arachidonate metabolites further supported 
this. HPLC revealed that P450 products were not produced in appreciable amounts in 
response to thapsigargin or PMA + thapsigargin. However, considering the extreme 
liability of P450 arachidonate epoxide metabolites, one must acknowledge the possibility 
that some P450 products might have gone undetected in our system. Thus, although 
results strongly suggest that a P450 arachidonate metabolite is not involved in 
capacitative calcium influx, we cannot conclusively rule it out.
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7.14 The primary product generated in response to thapsigargin stimulation in 
differentiated U937 cells, was free arachidonate itself.
Thin layer chromatography and HPLC suggested that the principal arachidonate 
metabolite generated during thapsigargin stimulated mobilization of arachidonate was 
the free fatty acid itself. Some prostaglandin metabolites were also produced, however 
these were inhibited by indomethacin without resulting in any inhibitory effects on 
[Ca2+]j elevation. Thus, prostaglandin metabolites are not coupled to generation of the 
CEF.
7.15 Free arachidonic acid may participate in generation of a CIF and 
activation of capacitative calcium influx.
Exogenous arachidonate stimulated a dose dependent increase in [Ca2+]i in 
differentiated U937 cells. The effects of exogenous arachidonate were dependent on 
extracellular calcium, consistent with a role for arachidonate in activation of capacitative 
calcium influx. The effects of exogenous arachidonate were not reproduced by either 
linoleic or oleic acids, indicating that these effects are relatively specific for 
arachidonate. Furthermore, exogenous arachidonate also stimulated release of 
endogenous arachidonate, presumably by activation of capacitative calcium entry. 
Exogenous arachidonate was without effect in undifferentiated cells, suggesting that 
free arachidonate is only a stimulus in those cells which possess a fully developed 
capacitative calcium influx pathway. Since CPLA2 activity is coupled to depletion of 
intracellular calcium stores, and inhibition of CPLA2 activity blocks capacitative calcium 
influx, it follows that free arachidonate generated by the action of CPLA2 may be a
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functional component of an intracellular effector system which serves as a link in the 
communication between intracellular calcium stores and SOC in the plasma membrane.
7.16 Model for receptor mediated activation of CPLA2.
A model for receptor-mediated activation of CPLA2  is presented in Figure 43. 
Agonists which stimulate PLC via either G-protein or tyrosine kinase linked receptors 
result in hydrolysis of PIP2, yielding diacylglycerol (DAG) and IP3.
IP3 binds a receptor on intracellular calcium stores, which results in rapid release 
of calcium from these stores. cPLAs present in the cytoplasm (possibly 
phosphorylated), is translocated to a locally high concentration of calcium surrounding 
intracellular stores. Calcium dependent association of CPLA2 with membrane substrates 
then initiates enzymatic activity and release of free arachidonate. This phase of 
arachidonate mobilization is sustained by [Ca2+],- elevations due to store depletion alone; 
influx of extracellular calcium is not required. Free arachidonate liberated in response to 
depletion of intracellular calcium stores participates in the formation of a calcium influx 
factor, possibly in conjunction with a low molecular weight GTPase, which directs the 
opening of SOC in the plasma membrane. Influx of extracellular calcium results in 
further activation of CPLA2, possibly translocated to the plasma membrane due to a 
locally high calcium concentration in the vicinity of SOC.
The role of phosphorylation as an in situ regulatory mechanism for CPLA2  
remains unclear. DAG generated as a consequence of PLC activation, may then 
activate PKC. PKC may have subsequent effects on either calcium channels or 
phosphorylation of CPLA2 directly. In the case of tyrosine kinase linked receptors, in
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FIGURE 44
REGULATION OF cPLA2 ACTIVITY IN AGONIST-STIMULATED SIGNAL
TRANSDUCTION
See text for description.
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addition to activation of PLC y, activation of MAP kinase may also result in 
phosphorylation of CPLA2 . Evidence suggests that phosphorylation in response to 
agonists such as PMA, cytokines, and bacterial endotoxin, enhances CPLA2 activity. 
However, phosphorylation alone does not appear to be sufficient stimulus for 
arachidonate release, unless coupled to a calcium signal. In differentiated U937 cells, 
PMA did not appear to affect arachidonate release coupled to intracellular calcium store 
depletion. PMA potentiation of thapsigargin-stimulated arachidonate release was 
primarily observed during influx of capacitative calcium. It is possible that 
phosphorylation stimulates coupling of CPLA2 to plasma membrane calcium influx 
channels. Alternatively, it is also possible that PMA effects are primarily on calcium 
influx channels, and arachidonate mobilization is enhanced by increased calcium influx.
In summary, this thesis suggests a novel role for cPLA2 in intracellular signal 
transduction. Agonists which activate IP3 dependent pathways are well known 
activators of CPLA2 . However it was assumed that the role of activated CPLA2  was 
solely to initiate the arachidonate cascade. Thus, CPLA2 is generally considered to be a 
consequence of nymediated signal transduction. Results presented in these 
experiments indicate that CPLA2 activation may be an integral component of IP3- 
mediated intracellular signaling. In fact, CPLA2 may be an intracellular effector system 
for propagation of the signal initiated by IP3, resulting in capacitative calcium influx.
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